0001213900-26-053981.txt : 20260508 0001213900-26-053981.hdr.sgml : 20260508 20260508170033 ACCESSION NUMBER: 0001213900-26-053981 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20260331 FILED AS OF DATE: 20260508 DATE AS OF CHANGE: 20260508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Keen Vision Acquisition Corp. CENTRAL INDEX KEY: 0001889983 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41753 FILM NUMBER: 26959466 BUSINESS ADDRESS: STREET 1: 37 GREENBRIAR DRIVE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (203) 609-1394 MAIL ADDRESS: STREET 1: 37 GREENBRIAR DRIVE CITY: SUMMIT STATE: NJ ZIP: 07901 10-Q 1 ea0289416-10q_keen.htm QUARTERLY REPORT kvac-20260331
http://fasb.org/srt/2026#ChiefExecutiveOfficerMember P3D 00-0000000 Q1 0001889983 false --12-31 0001889983 2026-01-01 2026-03-31 0001889983 us-gaap:SubsequentEventMember 2026-04-27 2026-04-27 0001889983 kvac:UnderwriterAgreementMember 2026-03-31 0001889983 kvac:UnderwriterAgreementMember 2026-01-01 2026-03-31 0001889983 2026-03-31 0001889983 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001889983 kvac:PublicWarrantMember 2026-01-01 2026-03-31 0001889983 us-gaap:WarrantMember 2026-03-31 0001889983 kvac:FounderShares1Member 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2025-12-31 0001889983 us-gaap:CommonStockMember 2026-03-31 0001889983 2025-12-31 0001889983 us-gaap:RelatedPartyMember 2025-12-31 0001889983 us-gaap:RelatedPartyMember 2026-03-31 0001889983 us-gaap:SubsequentEventMember kvac:SponsorMember 2026-04-27 0001889983 kvac:SponsorMember 2026-01-26 0001889983 kvac:SponsorMember 2025-12-19 0001889983 kvac:SponsorMember 2025-11-18 0001889983 kvac:SponsorMember 2025-10-21 0001889983 kvac:SponsorMember 2025-09-19 0001889983 kvac:SponsorMember 2025-08-18 0001889983 kvac:SponsorMember 2025-07-23 0001889983 kvac:SponsorMember 2025-06-23 2025-06-23 0001889983 kvac:SponsorMember 2025-05-20 2025-05-20 0001889983 kvac:SponsorMember 2025-04-25 2025-04-25 0001889983 kvac:SponsorMember 2025-03-24 2025-03-24 0001889983 kvac:SponsorMember 2025-02-24 2025-02-24 0001889983 kvac:SponsorMember 2025-01-22 2025-01-22 0001889983 kvac:SponsorMember 2024-12-23 2024-12-23 0001889983 kvac:SponsorMember 2024-11-20 2024-11-20 0001889983 kvac:SponsorMember 2024-10-28 2024-10-28 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-03-31 0001889983 2025-01-01 2025-03-31 0001889983 us-gaap:IPOMember kvac:FounderShares1Member 2021-09-30 2021-09-30 0001889983 2021-09-30 2021-09-30 0001889983 kvac:FounderShares1Member 2021-09-30 2021-09-30 0001889983 us-gaap:PrivatePlacementMember 2023-07-27 0001889983 kvac:PrivateWarrantsMember 2023-07-27 0001889983 kvac:PrivateWarrantsMember 2023-07-27 2023-07-27 0001889983 us-gaap:PrivatePlacementMember 2023-07-27 2023-07-27 0001889983 us-gaap:IPOMember 2026-03-31 0001889983 us-gaap:IPOMember kvac:PublicWarrantMember 2023-07-27 0001889983 kvac:PublicWarrantMember 2023-07-27 0001889983 kvac:PublicWarrantMember 2023-07-27 2023-07-27 0001889983 kvac:PublicShareMember 2023-07-27 2023-07-27 0001889983 us-gaap:OverAllotmentOptionMember 2023-07-27 0001889983 us-gaap:IPOMember kvac:PublicWarrantMember 2023-07-27 2023-07-27 0001889983 us-gaap:IPOMember 2023-07-27 0001889983 kvac:NonRedeemableOrdinaryShareMember 2024-01-01 2024-12-31 0001889983 kvac:RedeemableOrdinaryShareMember 2024-01-01 2024-12-31 0001889983 kvac:NonRedeemableOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 kvac:RedeemableOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 kvac:PrivateWarrantsMember 2025-12-31 0001889983 kvac:PrivateWarrantsMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 kvac:KVACMSCaymanLimitedMember 2026-01-01 2026-03-31 0001889983 kvac:KVACCaymanLimitedAcquirerMember 2026-01-01 2026-03-31 0001889983 kvac:PublicShareMember 2026-03-31 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-26 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember srt:ScenarioForecastMember 2026-04-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-12-19 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-11-18 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-10-21 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-09-19 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-08-18 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-06-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-05-20 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-04-25 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-03-24 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-02-24 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-01-22 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-12-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-11-20 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-10-28 0001889983 2026-01-22 2026-01-22 0001889983 2026-01-22 0001889983 srt:ScenarioForecastMember 2026-01-27 2026-07-27 0001889983 us-gaap:CommonStockMember 2025-07-22 2025-07-22 0001889983 2025-07-22 0001889983 2025-07-22 2025-07-22 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-22 0001889983 2025-07-27 0001889983 kvac:TrustAccountMember 2024-10-27 2025-07-27 0001889983 us-gaap:CommonStockMember 2024-10-25 2024-10-25 0001889983 2024-10-25 0001889983 2024-10-25 2024-10-25 0001889983 kvac:SponsorMember 2026-03-31 0001889983 us-gaap:IPOMember 2026-01-01 2026-03-31 0001889983 kvac:PublicShareMember 2026-01-01 2026-03-31 0001889983 2023-07-27 2023-07-27 0001889983 us-gaap:PrivatePlacementMember 2026-03-31 0001889983 us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0001889983 us-gaap:IPOMember 2023-07-27 2023-07-27 0001889983 2025-03-31 0001889983 2024-12-31 0001889983 us-gaap:RetainedEarningsMember 2025-03-31 0001889983 us-gaap:CommonStockMember 2025-03-31 0001889983 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001889983 us-gaap:RetainedEarningsMember 2024-12-31 0001889983 us-gaap:CommonStockMember 2024-12-31 0001889983 us-gaap:RetainedEarningsMember 2026-03-31 0001889983 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001889983 us-gaap:RetainedEarningsMember 2025-12-31 0001889983 kvac:OrdinarySharesNotSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001889983 kvac:OrdinarySharesNotSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0001889983 kvac:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001889983 kvac:OrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0001889983 2026-05-06 0001889983 kvac:WarrantsEachExercisableForOneOrdinaryShareAtAnExercisePriceOf1150Member 2026-01-01 2026-03-31 0001889983 kvac:OrdinaryShares00001ParValueMember 2026-01-01 2026-03-31 0001889983 kvac:UnitsEachConsistingOfOneOrdinaryShareAndOneRedeemableWarrantToAcquireOneOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001889983 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 iso4217:USD kvac:Segment xbrli:pure iso4217:USD xbrli:shares xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                   

 

Commission File No. 001-41753

 

KEEN VISION ACQUISITION CORPORATION
(Exact name of registrant as specified in its charter)

 

British Virgin Islands N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

37 Greenbriar Drive
Summit, New Jersey
 07901
(Address of Principal Executive Offices)   (Zip Code)

 

(203) 609-1394
(Registrant’s telephone number, including area code)

 

N/A
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share KVACU The Nasdaq Stock Market LLC
Ordinary Shares, $0.0001 par value KVAC The Nasdaq Stock Market LLC
Warrants KVACW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filerSmaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No ☐

 

As of May 6, 2026, there were 5,506,521 ordinary shares of the Registrant, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

KEEN VISION ACQUISITION CORPORATION

Quarterly Report on Form 10-Q

 

TABLE OF CONTENTS

 

    Page
PART I – FINANCIAL INFORMATION 1
     
Item 1. Financial Statements 1
     
  Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 1
     
  Unaudited Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2026 and 2025 2
     
  Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three Months Ended March 31, 2026 and 2025 3
     
  Unaudited Condensed Consolidated Statements of Cash Flows for Three Months Ended March 31, 2026 and 2025 4
     
  Notes to Unaudited Condensed Consolidated Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 24
     
Item 4. Control and Procedures 24
     
PART II – OTHER INFORMATION 25
     
Item 1. Legal Proceedings 25
     
Item 1A.  Risk Factors 25
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25
     
Item 3. Defaults Upon Senior Securities 26
     
Item 4. Mine Safety Disclosures 26
     
Item 5. Other Information 26
     
Item 6. Exhibits 26
     
SIGNATURES 27

 

i

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

KEEN VISION ACQUISITION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31,   December 31, 
   2026   2025 
   (unaudited)     
ASSETS        
Current assets:        
Cash at bank $9,098  $11,206 
Prepayment  95,225   25,550 
Total current assets  104,323   36,756 
Cash and investments held in trust account  13,153,709   57,003,115 
           
TOTAL ASSETS $13,258,032  $57,039,871 
           
LIABILITIES AND SHAREHOLDERS’ DEFICIT          
Current liabilities:          
Accrued expenses $106,907  $73,496 
Extension promissory note payable  2,788,022   2,668,022 
Amount due to a related party  1,582,880   1,315,880 
Total current liabilities  4,477,809   4,057,398 
           
Deferred underwriting compensation  2,990,000   2,990,000 
           
TOTAL LIABILITIES  7,467,809   7,047,398 
           
Commitments and contingencies (Note 7)  -   - 
           
Ordinary shares, 1,090,446 and 4,822,346 shares subject to possible redemption issued and outstanding as of March 31, 2026 and December 31, 2025, respectively  13,153,709   57,003,115 
           
Shareholders’ Deficit:          
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of March 31, 2026 and December 31, 2025 (excluding 1,090,446 and 4,822,346 shares subject to possible redemption, respectively)  442   442 
Accumulated deficit  (7,363,928)  (7,011,084)
           
Total Shareholders’ Deficit  (7,363,486)  (7,010,642)
           
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT $13,258,032  $57,039,871 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

1

 

 

KEEN VISION ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

   Three Months ended
March 31,
 
   2026   2025 
         
Formation and operating costs $(232,844) $(171,333)
           
Other income:          
Dividend income earned in investments held in Trust Account  324,931   739,504 
Total other income  324,931   739,504 
           
NET INCOME $92,087  $568,171 
           
Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption  3,163,724   6,404,652 
           
Basic and diluted net income per share, ordinary shares subject to possible redemption $0.07  $0.10 
           
Basic and diluted weighted average shares outstanding, ordinary shares not subject to possible redemption  4,416,075   4,416,075 
           
Basic and diluted net loss per share, attributable to ordinary shares not subject to possible redemption $(0.03) $(0.02)

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

2

 

 

KEEN VISION ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

 

   For the Three Months Ended
March 31, 2026
 
   Ordinary shares   Accumulated   Total
shareholder’s
 
   No. of shares   Amount   deficit   deficit 
                 
Balance as of January 1, 2026  4,416,075  $442  $(7,011,084) $(7,010,642)
                     
Accretion of carrying value to redemption value  -   -   (444,931)  (444,931)
Net income  -   -   92,087   92,087 
                     
Balance as of March 31, 2026  4,416,075  $442  $(7,363,928) $(7,363,486)

 

   For the Three Months Ended
March 31, 2025
 
   Ordinary shares   Accumulated   Total
shareholder’s
 
   No. of shares   Amount   deficit   deficit 
                 
Balance as of January 1, 2025  4,416,075  $442  $(4,199,554) $(4,199,112)
                     
Accretion of carrying value to redemption value  -   -   (1,339,504)  (1,339,504)
Net income  -   -   568,171   568,171 
                     
Balance as of March 31, 2025  4,416,075  $442  $(4,970,887) $(4,970,445)

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

3

 

 

KEEN VISION ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Three Months Ended
March 31,
 
   2026   2025 
Cash flows from operating activities:        
Net income $92,087  $568,171 
Adjustments to reconcile net income to net cash used in operating activities:          
Dividend income earned in cash and investments held in trust account  (324,931)  (739,504)
Changes in operating assets and liabilities:          
Prepayment  (69,675)  (62,860)
Accrued expenses  33,411   (74,013)
           
Net cash used in operating activities  (269,108)  (308,206)
           
Cash flows from investing activities:          
Extension payments deposited in Trust Account  (120,000)  (600,000)
Cash withdrawn from Trust Account in connection to redemption  44,294,337   - 
           
Net cash provided by (used in) investing activities  44,174,337   (600,000)
           
Cash flows from financing activities:          
Advance from a related party  267,000   269,622 
Proceed from extension promissory note payable - related party  120,000   600,000 
Redemption of common stock  (44,294,337)  - 
           
Net cash provided by (used in) financing activities  (43,907,337)  869,622 
           
NET CHANGE IN CASH  (2,108)  (38,584)
           
CASH AT BANK, BEGINNING OF PERIOD  11,206   54,548 
           
CASH AT BANK, END OF PERIOD $9,098  $15,964 
           
Non-cash investing and financing activities:          
Accretion of carrying value to redemption value $444,931  $1,339,504 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

4

 

 

KEEN VISION ACQUISITION CORPORATION 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND

 

Keen Vision Acquisition Corporation (the “Company” or “we”, “us” and “our”) is a blank check company incorporated on June 18, 2021, under the laws of the British Virgin Islands for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination.

 

The Company is an early stage company and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage companies and emerging growth companies. The Company has selected December 31 as its fiscal year end.

 

As of March 31, 2026, the Company had not commenced any operations. All activities through March 31, 2026 relate to the Company’s formation, the initial public offering (the “Initial Public Offering” or “IPO”) and activities necessary to identify a potential target and prepare for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income and changes in unrealized appreciation of Trust Account assets from the proceeds derived from the Initial Public Offering.

 

Financing

 

The registration statement for the Company’s Initial Public Offering was declared effective on July 24, 2023. On July 27, 2023, the Company consummated the Initial Public Offering of 14,950,000 units (the “Public Units”), which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at $10.00 per Public Unit, generating gross proceeds of $149,500,000 to the Company. Each Public Unit consists of one ordinary share (“Public Share”) and one redeemable warrant (“Public Warrant”) to purchase one ordinary share at an exercise price of $11.50 per share.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 678,575 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to KVC Sponsor LLC (the “Sponsor”), generating gross proceeds of $6,785,750 to the Company. Each Private Placement Unit consists of one ordinary share (“Private Placement Share”) and one redeemable warrant (“Private Warrant”) to purchase one ordinary share at an exercise price of $11.50 per whole share.

 

Transaction costs amounted to $6,597,980, consisting of $2,990,000 of underwriting commissions, $2,990,000 of deferred underwriting commissions and $617,980 of other offering costs. In addition, at July 27, 2023, cash of $1,593,452 was held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. Cash of $151,368,750 was transferred to the Trust Account on July 27, 2023.

 

Trust Account

 

The aggregate amount of $151,368,750 ($10.125 per Public Unit) held in a trust account (“Trust Account”) established for the benefit of the Company’s public shareholders and maintained by Continental Stock Transfer & Trust Company, acting as trustee, will be invested only in U.S. government treasury bills, with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds in the Trust Account will not be released until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period) or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the redemption of all of the Company’s public shares if the Company is unable to complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period), subject to applicable law.

  

5

 

 

Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

 

The Company will provide its shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with an Initial Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company shall not consummate such Business Combination unless (i) the Company has net tangible assets of at least US$5,000,001 after payment of the deferred underwriting commissions, either immediately prior to, or upon such consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such Business Combination; or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from seeking redemption rights with respect to 15% or more of the public shares without the Company’s prior written consent.

 

If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 

The shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially $10.125 per public share, subject to increase of up to an additional $0.10 per public share per each three-month extension in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their public shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

 

6

 

 

The Company will proceed with a Business Combination if (i) the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended; and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 

The Sponsor and any of the Company’s officers or directors that may hold Founder Shares (as described in Note 5) (as defined the “initial shareholders”) are identical to the Public Shares except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below. The Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial business combination, with respect thereto, a vote to amend the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, or a tender offer by the Company prior to a Business Combination.

 

On March 22, 2024, the Company entered into a non-binding letter of intent (the “LOI”) with a business combination target (the “Target”), regarding a potential business combination involving the Target and its subsidiaries (the “Proposed Transaction”). The Target is a clinical stage biopharmaceutical company based in Boston, U.S., focusing on i) the research, development, manufacture and use of self-developed pioneering human stem cell-based bioengineering technology platform for novel drug discovery; and ii) the development of next-generation cell and gene therapies for a range of difficult-to-treat or incurable diseases. With a pipeline of therapeutic candidates, the Target’s several experimental gene therapies have already obtained U.S. Food and Drug Administration (“FDA”) Investigational New Drug (IND) approvals as ongoing clinical trials at multiple premier hospitals in the U.S. with active patient enrolments.

 

The LOI is non-binding and no agreement providing for any Proposed Transaction or any other transaction or the participation by either party therein will be deemed to exist unless and until definitive agreements have been executed. Pursuant to the IPO prospectus dated July 24, 2023, (Registration No. 333-269659) filed by the Company for the initial public offering (the “IPO”), the Company is entitled to an automatic six-month extension to complete a business combination (the “Automatic Extension Period”) after the execution of the LOI and has 15 months from the closing of its IPO, or October 27, 2024, to complete its initial business combination period.

 

On September 3, 2024, the Company has entered into merger agreement (“Merger Agreement”) with Medera Inc. (“Medera”). The Company will incorporate a Cayman Islands exempted company (“Acquirer”) to be a direct wholly-owned subsidiary of the Company for the purpose of the merger of Company with and into the Acquirer (the “Reincorporation Merger”), in which Acquirer will be the surviving entity. Acquirer upon its incorporation will form a Cayman Islands exempted company to be a direct wholly-owned subsidiary of Acquirer (“Merger Sub”) for the purpose of effectuating the Acquisition Merger. Upon the terms and subject to the conditions of the Merger Agreement, (a) The Company will reincorporate by merging with and into the Acquirer, in which the Acquirer will be the surviving company and the Company will cease to exist, and (b) promptly after the Reincorporation Merger, the parties intend to effect a merger of Merger Sub with and into Medera, in which Medera will be the surviving entity (the “Acquisition Merger”, together with the Reincorporation Merger, the “Mergers” and together with the other transactions related thereto, the “Proposed Business Combination”).

 

At the effective time of the Acquisition Merger, each outstanding Medera Ordinary Share (excluding treasury shares and dissenting shares) will be cancelled and converted into the right to receive a number of Acquirer Ordinary Shares equal to the Exchange Ratio, as outlined in the Merger Agreement. The number of Acquirer Ordinary Shares to be delivered by Acquirer to shareholders of Medera at the Closing is based on a net value of $622,560,000 for 100% of Medera’s issued and outstanding ordinary shares, with each Acquirer Ordinary Share valued at $10.00.

 

On October 25, 2024, in connection with the stockholders vote at the Annual Meeting, 8,545,348 shares were redeemed by certain shareholders at a price of approximately $10.81 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $92,398,989.

 

7

 

 

On October 25, 2024, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment”). Pursuant to the Trust Amendment, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement for a period of nine months from October 27, 2024 to July 27, 2025, by depositing into the Trust Account $200,000 for all remaining public shares (the “Extension Payment”) for each one-month extension.

 

The Company will have until July 27, 2025 (unless further extended) to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within nine months (the “Combination Period”), the Company may extend the period of time to consummate a Business Combination up to four times, each by an additional one month each time (for a total of 24 months including Automatic Extension Period) by depositing into the Trust Account $200,000 (approximately $0.10 per share per each month extension) to complete a Business Combination (the “Paid Extension Period”). Any funds which may be provided to extend the time frame will be in the form of a loan to the Company from the Sponsor. The terms of any such loan have not been definitively negotiated, provided, however, any loan will be interest free and will be repayable only if the Company completes a Business Combination.

 

On July 22, 2025, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment II”). Pursuant to the Trust Amendment II, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement II for a period of nine months from July 27, 2025 to January 27, 2026, by depositing into the Trust Account $0.03 for each remaining public shares (the “Extension Payment”) for each one-month extension.

 

On July 22, 2025, in connection with the stockholders vote at the Annual Meeting, 1,582,306 shares were redeemed by certain shareholders at a price of approximately $11.43 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $18,091,743.

 

On January 22, 2026, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment III”). Pursuant to the Trust Amendment III, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement III for a period of seven months from January 27, 2026 to July, 2026, by depositing into the Trust Account $120,000 for all remaining public shares (the “Extension Payment”) for each three-month extension.

 

On January 22, 2026, in connection with the stockholders’ vote at the Annual Meeting, 3,781,900 shares were redeemed by certain shareholders at a price of approximately $11.71 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $44,294,337.

 

On February 26, 2026, the Company entered into a binding letter of intent (“LOI”) with Medera and Novoheart Group Limited, a British Virgin Islands company and wholly owned subsidiary of Medera (“NVH”). The LOI replaces the prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI pursuant to a mutual release agreement entered into by the parties. In connection with the execution of the LOI, the parties also executed a standard termination and mutual release agreement relating to the current Merger Agreement between the Company and Medera.

 

As of the date of this report, the Company has extended seventeen times, and so it now has until July 27, 2026 to consummate a business combination. Pursuant to the terms of the current amended and restated memorandum and articles of association and the trust agreement between the Company and Continental Stock Transfer & Trust Company, LLC, in order to extend the time available for the Company to consummate the initial business combination, the Company’s insiders or their affiliates or designees, must deposit into the Trust Account $200,000 on or prior to the date of the applicable deadline. On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, respectively, the Company has deposited in an amount of $200,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, respectively, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026.

 

8

 

 

Liquidation

 

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price of $10.00 per Public Unit.

 

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.125 per share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and going concern

 

As of March 31, 2026, the Company reported a working capital deficit of $4,373,486. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company initially had nine months from the consummation of the Initial Public Offering to consummate the initial Business Combination. If the Company does not complete a Business Combination within nine months from the consummation of the Initial Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Act (As Revised) of the British Virgin Islands. Accordingly, no vote would be required from the shareholders to commence such a voluntary winding up, dissolution and liquidation. However, the Company may extend the period of time to consummate a Business Combination seventeen times (for a total of up to 36 months from the consummation of the Initial Public Offering to complete a Business Combination, including Automatic Extension Period). If the Company is unable to consummate the Company’s Initial Business Combination by July 27, 2026 (unless further extended), the Company will, as promptly as possible but not more than ten business days thereafter, redeem 100% of the Company’s outstanding public shares for a pro rata portion of the funds held in the Trust Account, including a pro rata portion of any interest earned on the funds held in the Trust Account and not necessary to pay taxes, and then seek to liquidate and dissolve. However, the Company may not be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of the Company’s public shareholders. In the event of dissolution and liquidation, the Company’s warrants will expire and will be worthless.

 

Additionally, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not consummated by July 27, 2026 (unless further extended). These unaudited condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

9

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

These accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all of the information and notes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2025 included in the Company’s Form 10-K filed with the SEC on March 25, 2026. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the unaudited condensed financial statements of the Company and its subsidiaries. All significant intercompany transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.

 

A subsidiary is the entity in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:

 

Name   Background   Ownership
KVAC (Cayman) Limited (“Acquirer”)   A Cayman Islands company
Incorporated on August 28, 2024
  100% owned by the Company
KVAC MS (Cayman) Limited   A Cayman Islands company
Incorporated on July 10, 2024
  100% owned by the Acquirer

 

Emerging growth company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

10

 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2026 and December 31, 2025.

 

Cash and investment held in Trust Account

 

As of March 31, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. These securities are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividend income in the accompanying unaudited condensed consolidated statements of income and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets.

 

Warrant accounting

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

11

 

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.

 

As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.

 

Ordinary shares subject to possible redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of the Company’s control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively.

 

Fair value of financial instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. ASC 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judgment.

 

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by the market through correlation or other means.

 

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the unaudited condensed consolidated balance sheets. The fair values of cash and other current assets, accrued expenses, due to a related party are estimated to approximate the carrying values as of March 31, 2026 and December 31, 2025 due to the short maturities of such instruments.

  

12

 

 

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

    March 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2026     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 13,153,709     $ 13,153,709     $     -     $      -  

 

    December 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2025     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 57,003,115     $ 57,003,115     $      -     $      -  

 

Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited condensed consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the unaudited condensed consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s management determined that the British Virgin Islands and Cayman Islands are the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s tax provision was zero for the periods presented.

 

The Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands.

 

13

 

 

After the Initial Public Offering, the proceeds held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.

 

Net income (loss) per share

 

The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:

 

    For the Three Months Ended
March 31, 2026
    For the Three Months Ended
March 31, 2025
 
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
 
Basic and diluted net income (loss) per share:                        
Numerators:                        
Dividend income earned in investments held in Trust Account   $ 324,931     $ -     $ 739,504     $ -  
Total expenses     (97,186 )     (135,658 )     (101,410 )     (69,923 )
Total allocation to redeemable and non-redeemable ordinary shares   $ 227,745     $ (135,658 )   $ 638,094     $ (69,923 )
Denominators:                                
Weighted-average shares outstanding     3,163,724       4,416,075       6,404,652       4,416,075  
Basic and diluted net income (loss) per share   $ 0.07     $ (0.03 )   $ 0.10     $ (0.02 )

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.

 

14

 

 

Concentration of credit risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Recent issued accounting standards

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

 

NOTE 3 – INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering on July 27, 2023, the Company sold 14,950,000 Public Units, which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at a purchase price of $10.00 per Public Unit. Each Public Unit consists of one Public Share and one Public Warrant to purchase one ordinary share at an exercise price of $11.50 per share (see Note 6).

 

All of the 14,950,000 public shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

 

The Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).

 

NOTE 4 – PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering on July 27, 2023, the Company consummated a private placement of 678,575 Private Placement Units, at a price of $10.00 per Private Placement Unit. Each Private Placement Unit consists of one Private Placement share and one Private Warrant to purchase one ordinary share at an exercise price of $11.50 per whole share.

 

The Private Placement Units are identical to the Public Units sold in the Initial Public Offering except for certain registration rights and transfer restrictions.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Founder Shares

 

In September 2021, the Company issued an aggregate of 3,737,500 Founder Shares to the initial shareholders, including an aggregate of up to 487,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (see Note 6) for an aggregate purchase price of $25,000. As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (See Note 7).

 

15

 

 

Administrative Services Arrangement

 

An affiliate of the Sponsor agreed that, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, administrative and support services, as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $10,000 per month for these services commencing on the closing date of the Initial Public Offering for 15 months (or up to 21 months including Automatic Extension Period). As of March 31, 2026 and December 31, 2025, the unpaid services fee was $150,000 and $120,000, respectively, and is presented in amount due to a related party in the accompanying unaudited condensed consolidated balance sheets. For the three months ended March 31, 2026 and 2025, the Company incurred $30,000 and $30,000 in fees for these services, respectively.

 

Related Party Extensions Loan

 

The Company will have to consummate a Business Combination by July 27, 2026. However, if the Company anticipates that it may not be able to consummate a Business Combination within 21 months (including automatic extension period), the Company may extend the period of time to consummate a Business Combination up to four times, four times by an additional one month each time to complete a Business Combination. The Sponsor or its affiliates or designees will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the event that the Company are unable to close a Business Combination unless there are funds available outside the Trust Account to do so. Such notes would either be paid upon consummation of the initial Business Combination or at the lender’s discretion, converted upon consummation of the Business Combination into additional private units at a price of $10.00 per unit.

 

On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, the Company issued an unsecured promissory note in an amount of $200,000 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. The notes are non-interest bearing and are payable upon the closing of a business combination. In addition, the notes may be converted, at the lender’s discretion, into additional Private Units at a price of $10.00 per unit. As of March 31, 2026 and December 31, 2025, the note payable balance was $2,788,022 and $2,668,022, respectively.

  

Advance from a Related Party

 

As of March 31, 2026 and December 31, 2025, the Company had a temporary advance of $1,582,880 and $1,315,880 from the Sponsor, respectively. The balance is unsecured, interest-free and has no fixed terms of repayment. 

 

NOTE 6 – SHAREHOLDERS’ DEFICIT

 

Ordinary Shares

 

The Company is authorized to issue 500,000,000 ordinary shares at par $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share.

 

As of March 31, 2026 and December 31, 2025, 4,416,075 and 4,416,075 Ordinary Shares were issued and outstanding excluding 1,090,446 and 4,822,346 Ordinary Shares subject to possible redemption, respectively, so that the initial shareholders will own 20% of the issued and outstanding shares after the Initial Public Offering (excluding the sale of the Private Units and assuming the initial shareholders do not purchase any Units in the Initial Public Offering). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (see Note 7).

 

16

 

 

Warrants

 

Each holder of a warrant shall be entitled to purchase one ordinary share at an exercise price of $11.50. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable after the consummation of a Business Combination. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. The Company has agreed that as soon as practicable after the closing of a Business Combination, the Company will use its best efforts to file, and within 90 days following a Business Combination to have declared effective, a registration statement covering the ordinary shares issuable upon exercise of the warrants. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 90 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

 

The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant:

 

  upon not less than 30 days’ prior written notice of redemption to each warrant holder,

 

  if, and only if, the reported last sale price of the ordinary share equals or exceeds $16.5 per share, for any 20 trading days within a 30 trading days period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and

 

  if, and only if, there is a current registration statement in effect with respect to the issuance of the ordinary share underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

 

In addition, if in connection with a Business Combination, the Company (a) issues additional Ordinary Shares or equity-linked securities at an issue price or effective issue price of less than $9.35 per share (with such issue price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such issuance to the Company’s initial stockholders, or their affiliates, without taking into account any Founders’ Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions), and (c) the Fair Market Value (as defined below) is below $9.35 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (a) the Fair Market Value or (b) the price at which the Company issues the ordinary shares or equity-linked securities, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Fair Market Value and the price at which the Company issues ordinary shares or equity-linked securities. The “Fair Market Value” shall mean the volume weighted average reported trading price of the ordinary shares for the twenty (20) trading days starting on the trading day prior to the date of the consummation of the Business Combination.

 

The Private Warrants are identical to the Public Warrants underlying the Public Units being sold in the Initial Public Offering except that Private Placement Units will not be transferable, assignable or saleable until 30 days after the completion of the Company’s Business Combination and will be entitled to registration rights.

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the Russia-Ukraine war and the conflict in Israel and Palestine on the industry and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

17

 

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on July 24, 2023, the holders of the Founder Shares, Private Placement Units (including securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital loans or extension loans and are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriter Agreement

 

The underwriters are entitled to a cash underwriting discount of 2% of the gross proceeds of the Initial Public Offering, or $2,990,000, upon the closing of the Business Combination, which is shown as deferred underwriting expenses on the accompanying unaudited condensed consolidated balance sheets.

 

NOTE 8 – SEGMENT INFORMATION

 

ASC Topic 280, Segment Reporting, establishes standards for companies to report in their unaudited condensed financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which includes formation and operating costs and interest and dividend earned on investments held in Trust Account which are included in the accompanying statements of income.

 

The key measures of segment profit or loss reviewed by the CODM are earned on investments held in Trust Account and formation and operating costs. The CODM reviewed earned on investments held in Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

 

NOTE 9 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the unaudited condensed consolidated balance sheet date, the Company has evaluated all events or transactions that occurred after the unaudited condensed consolidated balance sheet date.

 

On April 27, 2026 the Company issued an unsecured promissory note in an amount of $120,000 to the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026.

 

18

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Keen Vision Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to KVC Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s registration statement on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at http://www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company formed under the laws of the British Virgin Islands on June 18, 2021, and for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities, which we refer to throughout this Quarterly Report as our initial business combination. We have not selected any business combination target with respect to the initial business combination.

 

On July 27, 2023, we consummated our Initial Public Offering of 14,950,000 units (the “Units”), inclusive of the over-allotment option of 1,950,000 Units. Each Unit consisted of one ordinary share, par value US$0.0001 per share and one redeemable warrant. Our Registration Statement on Form S-1 for the Initial Public Offering was declared effective by the SEC on July 24, 2023. EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), and Brookline Capital Markets, a division of Arcadia Securities, LLC (“Brookline”) acted as an underwriter for the Initial Public Offering. The Units were sold at an offering price of US$10.00 per Unit, generating gross proceeds of US$149,500,000.

 

19

 

 

Simultaneously with the closing of the Initial Public Offering on July 27, 2023, we consummated the sale of 678,575 Private Placement Units. The Private Placement Units were sold at a price of US$10.00 per Private Placement Unit in the private placement, generating gross proceeds of US$6,785,750.

 

Transaction costs amounted to US$6,597,980, consisting of US$2,990,000 of underwriting commissions, US$2,990,000 of deferred underwriting commissions and US$617,980 of other offering costs.

 

On March 22, 2024, the Company entered into a non-binding letter of intent (the “LOI”) with a business combination target (the “Target”), regarding a potential business combination involving the Target and its subsidiaries (the “Proposed Transaction”). The Target is a clinical stage biopharmaceutical company based in Boston, U.S., focusing on i) the research, development, manufacture and use of self-developed pioneering human stem cell-based bioengineering technology platform for novel drug discovery; and ii) the development of next-generation cell and gene therapies for a range of difficult-to-treat or incurable diseases. With a pipeline of therapeutic candidates, the Target’s several experimental gene therapies have already obtained U.S. Food and Drug Administration (“FDA”) Investigational New Drug (IND) approvals as ongoing clinical trials at multiple premier hospitals in the U.S. with active patient enrolments. The LOI is non-binding and no agreement providing for any Proposed Transaction or any other transaction or the participation by either party therein will be deemed to exist unless and until definitive agreements have been executed.

 

Pursuant to the IPO prospectus dated July 24, 2023 (Registration No. 333-269659) filed by KVAC for the IPO, the Company is entitled to an automatic six-month extension to complete a business combination (the “Automatic Extension Period”) after the execution of the LOI and has 15 months from the closing of its IPO to complete its initial business combination period.

 

On September 3, 2024, the Company has entered into merger agreement (“Merger Agreement”) with Medera Inc. (“Medera”). The Company will incorporate a Cayman Islands exempted company (“Acquirer”) to be a direct wholly-owned subsidiary of the Company for the purpose of the merger of Company with and into the Acquirer (the “Reincorporation Merger”), in which Acquirer will be the surviving entity. Acquirer upon its incorporation will form a Cayman Islands exempted company to be a direct wholly-owned subsidiary of Acquirer (“Merger Sub”) for the purpose of effectuating the Acquisition Merger. Upon the terms and subject to the conditions of the Merger Agreement, (a) The Company will reincorporate by merging with and into the Acquirer, in which the Acquirer will be the surviving company and the Company will cease to exist, and (b) promptly after the Reincorporation Merger, the parties intend to effect a merger of Merger Sub with and into Medera, in which Medera will be the surviving entity (the “Acquisition Merger”, together with the Reincorporation Merger, the “Mergers” and together with the other transactions related thereto, the “Proposed Business Combination”).

 

At the effective time of the Acquisition Merger, each outstanding Medera Ordinary Share (excluding treasury shares and dissenting shares) will be cancelled and converted into the right to receive a number of Acquirer Ordinary Shares equal to the Exchange Ratio, as outlined in the Merger Agreement. The number of Acquirer Ordinary Shares to be delivered by Acquirer to shareholders of Medera at the Closing is based on a net value of $622,560,000 for 100% of Medera’s issued and outstanding ordinary shares, with each Acquirer Ordinary Share valued at $10.00.

 

On February 26, 2026, the Company entered into a binding letter of intent (“LOI II”) with Medera, and Novoheart Group Limited, a British Virgin Islands company and wholly owned subsidiary of Medera (“NVH”). The LOI II replaces the prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI II pursuant to a mutual release agreement entered into by the parties.

 

Under the LOI II, the Company and NVH have agreed to use their best efforts to negotiate and execute a replacement merger agreement (“Replacement Merger Agreement”) no later than April 10, 2026. The Replacement Merger Agreement will be based on the terms and conditions of the prior Merger Agreement, modified as necessary to reflect the parties’ current agreements set forth in the LOI II. The contemplated transaction involves a merger of NVH, which is principally engaged in pre-clinical human disease modeling, drug discovery, and related technologies, with and into Parent, with the Company as the surviving company and listed on Nasdaq. The final acquisition structure and jurisdiction of the combined company will be determined following due diligence and will be optimized for tax outcomes for existing equity holders of the Company and NVH. The parties entered into an amendment to the LOI II dated April 14, 2026, pursuant to which the parties agreed to extend the deadline for execution of the Replacement Merger Agreement from April 10, 2026 to April 30, 2026. As of May 6, 2026, the Company has not yet executed the Replacement Merger Agreement and continues to work toward its execution.

 

20

 

 

On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, the Company issued an unsecured promissory note in an amount of $200,000 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025 and October 21, 2025, November 18, 2025 and December 19, 2025, the Company issued an unsecured promissory note in an amount of $144,670.38 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company issued an unsecured promissory note in an amount of $120,000 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. The Note does not bear interest and matures upon the closing of a business combination by the Company. In addition, the Note may be converted by the holder into units of the Company identical to the units issued in the Company’s initial public offering at a price of $10.00 per unit.

 

Results of Operations

 

All activity from inception up to March 31, 2026 related to our formation and the Initial Public Offering. Since the Initial Public Offering, our activity has been limited to the evaluation of Business Combination candidates, and we will not be generating any operating revenues until the closing and completion of our initial Business Combination. We incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well due diligence expenses in connection with our searches for business combination targets.

 

For the three months ended March 31, 2026, we had a net income of $92,087, which comprised of general and administrative expenses and dividend income.

 

For the three months ended March 31, 2025, we had a net income of $568,171, which comprised of general and administrative expenses and dividend income.

 

Liquidity and Capital Resources

 

As of March 31, 2026, we had cash of $9,098. Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of ordinary shares by the Sponsor, loans provided by the Sponsor under a certain unsecured promissory note and advances from the Sponsor.

 

On July 27, 2023, we consummated the Initial Public Offering of 14,950,000 Units, including 1,950,000 Units upon the full exercise of the underwriter’s over-allotment option. Each Unit consists of one ordinary share and one warrant. Each Warrant entitling its holder to purchase one ordinary share at a price of US$11.50 per share. The Units were sold at an offering price of US$10.00 per Unit, generating gross proceeds of US$149,500,000.

 

As of July 27, 2023, a total of US$151,368,750 of the net proceeds from the Initial Public Offering and the private placement consummated simultaneously with the closing of the Initial Public Offering were deposited in the Trust Account established for the benefit of our public shareholders.

 

We intend to use substantially all of the net proceeds of the Initial Public Offering, including the funds held in the Trust Account, to acquire a target business or businesses and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration to effect our Business Combination, the remaining proceeds held in the Trust Account, as well as any other net proceeds not expended, will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our Business Combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.

 

21

 

 

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability to continue as a going concern if a Business Combination is not consummated July 27, 2026 (unless further extended). These unaudited condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

 

Off-balance sheet financing agreements

 

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as of March 31, 2026 and December 31, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on July 24, 2023, the holders of the Founder Shares, Private Placement Units (including securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital loans or extension loans and are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of this offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company’s register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company completion of initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters are entitled to a cash underwriting discount of 2% of the gross proceeds of the Initial Public Offering, or $2,990,000, upon the closing of the Business Combination.

 

22

 

 

Critical Accounting Policies

 

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following significant accounting estimates and accounting policies:

 

Ordinary Shares Subject to Possible Redemption

 

We accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of our control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively.

 

Warrant accounting

 

We account accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.

 

As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.

 

Net income (loss) per share

 

The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

23

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

We are a smaller reporting company and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2026, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting

 

During the quarter ended March 31, 2026, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

As a smaller reporting company, we are not required to make disclosures under this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On July 27, 2023, we consummated the Initial Public Offering of 14,950,000 Units (including 1,950,000 over-allotment units), each Unit consisting of one ordinary share and one redeemable warrant, for $10.00 per Unit, generating gross proceeds of $149,500,000. Each warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustment.

 

The securities in the Initial Public Offering, including the exercise by the underwriters of the over-allotment option, were registered under the Securities Act on a registration statement on Form S-1 (No. 333-269659). The SEC declared the registration statement effective on July 24, 2023.

 

On July 27, 2023, simultaneously with the closing of the Initial Public Offering, we sold an aggregate of 678,575 Private Units in a private placement with the Sponsor, at a price of $10.00 per Private Unit, generating gross proceeds of $ 6,785,750. The Private Units are identical to the units sold in the Initial Public Offering, except as otherwise disclosed in the registration statement. No underwriting discounts or commissions were paid with respect to such sale.

 

A total of $151,368,750 of the net proceeds from the sale of the Units in the Initial Public Offering and the private placement of the Private Units on July 27, 2023, were deposited in a trust account established for the benefit of the Company’s public stockholders at JPMorgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee.

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report.

 

25

 

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

 

Exhibit No.   Description
2.1+   Merger Agreement dated September 3, 2024 (incorporated by reference to Exhibit 2.1 to Keen Vision’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2024)
2.2+   Joinder agreement to the Merger Agreement dated September 16, 2024 (incorporated by reference to Exhibit 2.2 to Keen Vision’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 6, 2025)
2.3+   Termination and Mutual Release Agreement entered by and between the Parent and the Company dated February 26, 2026 (incorporated by reference to Exhibit 10.2 to Keen Vision’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026)
2.4+   Letter of Intent dated February 26, 2026 entered by and between the Parent and the Company (incorporated by reference to Exhibit 10.1 to Keen Vision’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026)
2.5*   Amendment to Binding Letter of Intent dated April 14, 2026 entered by and between the Parent and the Company
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2* Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith.
** Furnished herewith. This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
+ Previously filed and incorporated by reference

 

26

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  KEEN VISION ACQUISITION CORPORATION
     
Date: May 8, 2026 By: /s/ WONG, Kenneth K.C.
  Name:  WONG, Kenneth K.C.
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
Date: May 8, 2026 By: /s/ DAVIDKHANIAN, Alex
  Name:  DAVIDKHANIAN, Alex
  Title: Chief Financial Officer
    (Principal Accounting and Financial
Officer)

 

 

27

 

 

EX-2.5 2 ea028941601ex2-5.htm AMENDMENT TO BINDING LETTER OF INTENT DATED APRIL 14, 2026 ENTERED BY AND BETWEEN THE PARENT AND THE COMPANY

Exhibit 2.5

 

Keen Vision Acquisition Corporation

 

 

Kenneth KC Wong

Chairman/Chief Executive Officer

 

Strictly Private and Confidential

 

April 14, 2026

 

Professor Ronald A. Li, Chief Executive Officer

Medera Inc.

Novoheart Group Inc.

6 Tide Street, 2nd Floor,

Boston, MA 02210

 

Dear Sir,

 

RE: AMENDMENT TO BINDING LETTER OF INTENT DATED FEBRUARY 26, 2026

 

I refer to the binding letter of intent dated February 26, 2026 by and among Medera Inc., Novoheart Group Limited and Keen Vision Acquisition Corporation (the “LOI”). All defined terms in this letter shall have the respective meanings ascribed to them in the LOI.

 

Pursuant to our discussions, the Parties agree to extend the deadline for execution of the Replacement Merger Agreement from April 10, 2026 to April 30, 2026. Accordingly, the references in the LOI to “April 10, 2026” in Recital D and paragraph 3 of the LOI are each hereby deleted and replaced by “April 30, 2026.”

 

Except as so amended, the LOI remains in full force and effect.

 

[SIGNATURE PAGE TO FOLLOW] 

 

 

 

Amendment of LOI dated February 26, 2026

 

 

Page 2/2

 

If the foregoing correctly sets forth our understanding with respect to the amendment of the LOI, please so confirm by signing and returning one copy of this letter.

 

Very truly yours,  
   
/s/ Kenneth KC Wong  
For and on behalf of  
Keen Vision Acquisition Corporation  
Name: Kenneth KC Wong  
Position:  Chief Executive Officer  

 

  Confirmed and agreed to this 14th day of April, 2026:
     
  For and on behalf of
  Medera Inc.
     
  /s/ Ronald A. Li
  Name: Ronald A. Li
  Position:  Chief Executive Officer
     
  Accepted and Agreed for and on behalf of
  Novoheart Group Ltd.
   
     
  /s/ Ronald A. Li
  Name: Ronald A. Li
  Position: Chief Executive Officer

 

EX-31.1 3 ea028941601ex31-1.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, WONG, Kenneth K.C., certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Keen Vision Acquisition Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2026

 

  /s/ WONG, Kenneth K.C.
  WONG, Kenneth K.C.
  Director and Chief Executive Officer
  (Principal Executive Officer)

 

EX-31.2 4 ea028941601ex31-2.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, DAVIDKHANIAN, Alex, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Keen Vision Acquisition Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2026

 

  /s/ DAVIDKHANIAN, Alex
  DAVIDKHANIAN, Alex
  Chief Financial Officer and Director
  (Principal Financial and Accounting Officer)

 

EX-32.1 5 ea028941601ex32-1.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Keen Vision Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission (the “Report”), I, WONG, Kenneth K.C., Chief Executive Officer and director of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 8, 2026

 

  /s/ WONG, Kenneth K.C.
  WONG, Kenneth K.C.
  Director and Chief Executive Officer
  (Principal Executive Officer)

 

EX-32.2 6 ea028941601ex32-2.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Keen Vision Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission (the “Report”), I, DAVIDKHANIAN, Alex, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 8, 2026

 

  /s/ DAVIDKHANIAN, Alex
  DAVIDKHANIAN, Alex
  Chief Financial Officer and Director
  (Principal Financial and Accounting Officer)

 

EX-101.SCH 7 kvac-20260331.xsd XBRL SCHEMA FILE 995300 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 995301 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 995302 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 995303 - Statement - Unaudited Condensed Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 995304 - Statement - Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 995305 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995306 - Disclosure - Organization and Business Background link:presentationLink link:calculationLink link:definitionLink 995307 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995308 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 995309 - Disclosure - Private Placement link:presentationLink link:calculationLink link:definitionLink 995310 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995311 - Disclosure - Shareholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 995312 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995313 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995314 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 996315 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 996316 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 996317 - Disclosure - Organization and Business Background (Details) link:presentationLink link:calculationLink link:definitionLink 996318 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 996319 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 996320 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) link:presentationLink link:calculationLink link:definitionLink 996321 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 996322 - Disclosure - Initial Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 996323 - Disclosure - Private Placement (Details) link:presentationLink link:calculationLink link:definitionLink 996324 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 996325 - Disclosure - Shareholders’ Deficit (Details) link:presentationLink link:calculationLink link:definitionLink 996326 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 996327 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 996328 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 kvac-20260331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 kvac-20260331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 kvac-20260331_lab.xml XBRL LABEL FILE Cash and investment held in trust account Cash And Investment Held In Trust Account Policy Text Block Disclosure of accounting policy for cash and investment held in trust account. Emerging growth company Emerging Growth Company Policy Text Block The entire disclosure for emerging growth company. Related parties Related Parties Policy Policy Text Block Disclosure of accounting policy for related parties. Warrant accounting Warrant Accounting Policy Text Block The disclosure of accounting warrant accounting. Summary of Significant Accounting Policies [Abstract] Basis of presentation Basis of Accounting [Text Block] Cash Cash and Cash Equivalents, Policy [Policy Text Block] Concentration of credit risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Principles of consolidation Consolidation, Policy [Policy Text Block] Net income (loss) per share Earnings Per Share, Policy [Policy Text Block] Fair value of financial instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Income taxes Income Tax, Policy [Policy Text Block] Recent issued accounting standards New Accounting Pronouncements, Policy [Policy Text Block] Ordinary shares subject to possible redemption Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block] Use of estimates Use of Estimates, Policy [Policy Text Block] Schedule of Fair Value Hierarchy of the Valuation Techniques Fair Value, Assets Measured on Recurring Basis [Table Text Block] Note payable Extension promissory note payable Other Notes Payable, Current Fees incurred Payments for Other Fees Payment for month rent Payments for Rent Issued an unsecured promissory note Unsecured promissory note Proceeds from Unsecured Notes Payable Related and Nonrelated Parties [Domain] Private Placement (Details) [Table] Private Warrants [Member] Private Warrants Member Number of units Sale of public units Company consummated sale (in Shares) Units Issued During Period Shares New Issues Number of new units issued during the period. Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Exercise price (in Dollars per share) Exercise price Exercise price per share (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Private Placement [Line Items] Purchase of each warrant Purchase of each warrant (in Shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Private Placement [Member] Private Placement [Member] KVAC MS (Cayman) Limited [Member] KVACMSCayman Limited Member Schedule Of Consolidated Financial Statements Abstract Ownership [Axis] Ownership [Domain] Subsidiary of LLC or LP [Table] Background Subsidiary of Limited Liability Company or Limited Partnership, Business Purpose Schedule of Consolidated Financial Statements [Line Items] Ownership Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest Schedule Of Fair Value Hierarchy Of The Valuation Techniques Abstract Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) [Table] Assets: Assets [Abstract] U.S. Treasury Securities held in Trust Account Cash and investments held in trust account Asset, Held-in-Trust, Noncurrent Schedule of Fair Value Hierarchy of the Valuation Techniques [Line Items] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Quoted Prices In Active Markets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Deposit Deposits Equity Component [Domain] Initial Public Offering [Member] IPO [Member] Organization and Business Background [Abstract] Underwriting commissions Other Underwriting Expense Over-Allotment Option [Member] Over-Allotment Option [Member] Gross proceeds Proceeds from Issuance Initial Public Offering Gross proceeds from private Proceeds from Issuance of Private Placement Deposit amount Deposit Assets, Total Other offering costs Deferred Offering Costs Deferred underwriting commissions Deferred underwriting compensation Deferred underwriting expenses Deferred Compensation Liability, Classified, Noncurrent Common Stock [Member] Ordinary shares Common Stock [Member] Voting securities, percentage Business Combination, Voting Equity Interest Acquired, Percentage Organization and Business Background [Line Items] Business Combination [Axis] Business Combination [Domain] Cash held outside trust account Deposited into the trust account Asset, Held-in-Trust Cash transferred to trust account Asset Acquisition, Consideration Transferred Scenario [Axis] Scenario [Domain] Services fee Service Fees Unpaid Represents the amount of service fees paid. Sponsor [Member] Sponsor Member Warrants to purchase aggregate shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Summary of Significant Accounting Policies [Line Items] Ordinary shares subject to possible redemption Shares subject to possible redemption, shares outstanding (in Shares) Ordinary shares subject to possible redemption outstanding Temporary Equity, Shares Outstanding Accrued for interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Percentage of market value Percentage Of Market Value Percentage of market value. Price threshold fair market value of exercise of warrants Price Threshold Fair Market Value Of Exercise Of Warrants Price threshold fair market value of exercise of warrants. Effective issue price per share Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price Price threshold of newly issued stock to cause adjustment of exercise warrant price. Aggregate gross proceeds percentage Proceeds To Be Used For Business Combination As APercentage Of Total Capital Raising Proceeds to be used for business combination as a percentage of total capital raising. Public Warrant [Member] Public Warrant Member Public warrant [Member]. Redemption trigger price Redemption Trigger Price Redemption trigger price per share. Shareholders’ Deficit (Details) [Table] Threshold period for effective within statement after business combination Threshold Period For Effective With In Statement After Business Combination Represent the number of threshold days for effective with in statement after business combination. Threshold period for not effective within statement after business combination Threshold Period For Not Effective Within Statement After Business Combination Represent the number of threshold days for not effective within statement after business combination. Shareholders’ Deficit [Line Items] Initial Public Offering [Line Items] Current Fiscal Year End Date Subsequent Event Type [Domain] Amendment Flag City Area Code Cover [Abstract] Ordinary Shares Subject to Possible Redemption Ordinary Shares Subject To Possible Redemption Member Class of Stock [Domain] Document Information [Line Items] Document Information [Table] Document Fiscal Year Focus NET INCOME Net income Net income Total other income Nonoperating Income (Expense) Document Period End Date Document Transition Report Document Type Ordinary Shares Not Subject to Possible Redemption Ordinary Shares Not Subject To Possible Redemption Member Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Common Stock, Shares Outstanding Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of December 31, 2025 and 2024 (excluding 4,822,346 and 14,950,000 shares subject to possible redemption, respectively) Common Stock, Value, Issued TOTAL LIABILITIES Liabilities TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT Liabilities and Equity Total current liabilities Liabilities, Current Current liabilities: Liabilities, Current [Abstract] Proceed from extension promissory note payable - related party Proceeds from Notes Payable Advance from a related party Proceeds from Related Party Debt ORGANIZATION AND BUSINESS BACKGROUND Nature of Operations [Text Block] Entity Registrant Name Entity Shell Company Entity Small Business Entity Tax Identification Number SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Initial Public Offering [Abstract] INITIAL PUBLIC OFFERING Initial Public Offering Text Block The entire disclosure on information about initial public offering. Private Placement [Abstract] PRIVATE PLACEMENT Private Placements Text Block The entire disclosure of private placement. Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Accrued expenses Increase (Decrease) in Accrued Liabilities Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Prepayment Increase (Decrease) in Prepaid Expense Subsequent Event Type [Axis] Related Party Transaction [Domain] Equity Components [Axis] Ordinary shares subject to possible redemption issued Shares subject to possible redemption, shares issued (in Shares) Temporary Equity, Shares Issued Warrant [Member] Warrant [Member] Warrants term Warrants and Rights Outstanding, Term Commitments and Contingencies (Details) [Table] Underwriter Agreement [Member] Underwriter Agreement Member Related Party Transactions [Abstract] Related and Nonrelated Parties [Axis] Sale of Stock [Domain] Price per unit (in Dollars per share) Sale of Stock, Price Per Share Business Combination [Member] Business Combination, Series of Individually Immaterial Business Combinations [Member] Aggregate shares (in Shares) Stock Issued During Period, Shares, New Issues Shares subject to forfeiture (in Shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) Weighted Average Number of Shares Outstanding, Diluted Basic weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) Weighted-average shares outstanding (in Shares) Weighted Average Number of Shares Outstanding, Basic Amount due to a related party Temporary advance Other Liabilities, Current Trading Symbol Local Phone Number Title of 12(b) Security Security Exchange Name Basic net income per share, ordinary shares subject to possible redemption (in Dollars per share) Basic net income (loss) per share (in Dollars per share) Earnings Per Share, Basic Diluted net income per share, ordinary shares subject to possible redemption (in Dollars per share) Diluted net income (loss) per share (in Dollars per share) Earnings Per Share, Diluted Income Statement [Abstract] Dividend income earned in cash and investments held in trust account Dividend income earned in investments held in Trust Account Investment Income, Dividend Accumulated deficit Retained Earnings [Member] Balance (in Shares) Balance (in Shares) Shares, Outstanding Statement [Line Items] Statement of Stockholders' Equity [Abstract] Statement [Table] Balance Balance Total Shareholders’ Deficit Equity, Attributable to Parent Accretion of carrying value to redemption value Temporary Equity, Accretion to Redemption Value Accretion of carrying value to redemption value Accrued Underwriting Compensations It represents the amount of accrued underwriting compensation. Cash withdrawn from Trust Account in connection to redemption Cash Withdrawn From Trust Account In Connection To Redemption Proceeds from withdrawn from Trust Account in connection to redemption. Adjustments to reconcile net income to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] CASH AT BANK, END OF PERIOD CASH AT BANK, BEGINNING OF PERIOD Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation NET CHANGE IN CASH Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Ordinary shares, 4,822,346 and 14,950,000 shares subject to possible redemption issued and outstanding as of December 31, 2025 and 2024, respectively Temporary Equity, Carrying Amount, Attributable to Parent Ordinary shares, par value (in Dollars per share) Ordinary shares, par value Common Stock, Par or Stated Value Per Share Ordinary shares, shares authorized (in Shares) Ordinary shares, shares authorized Common Stock, Shares Authorized Formation and operating costs Operating Costs and Expenses Other income: Component of Operating Income [Abstract] Class of Stock [Axis] Net cash provided by (used in) financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Document Quarterly Report Shareholders’ Deficit [Abstract] SHAREHOLDERS’ DEFICIT Equity [Text Block] Commitments and Contingencies [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Segment Information [Abstract] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Subsequent Events [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Consolidated Financial Statements Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block] Entity [Domain] Legal Entity [Axis] Aggregate of held in trust account Aggregate Of Held In Trust Account Aggregate of held in trust account. Closing net value Closing Net Value Closing net value. Depositing amount to trust account Depositing Amount To Trust Account Depositing amount to trust account. Maturity period Maturity Invested Term The maturity invested term. Dissolution expenses Maximum Net Interest To Pay Dissolution Expenses "Represents the maximum net interest to pay dissolution expenses. " Net tangible assets Minimum Net Tangible Assets Upon Consummation Of Business Combination Amount of net tangible assets upon consummation of business. Organization and Business Background (Details) [Table] Aggregate amount Payment of Aggregate Amount Represent the amount of aggregate amount. Outstanding public shares, percentage Percentage Obligation To Redeem Public Shares Percentage of shares which the reporting entity is obligated to redeem. Percentage of aggregate fair market value Percentage Of Aggregate Fair Market Value Of Asset Represents the minimum percentage of aggregate fair market value of assets. Percentage of issued and outstanding ordinary shares Percentage Of Issued And Outstanding Ordinary Shares Percentage of issued and outstanding ordinary shares. Purchase price per unit (in Dollars per share) Price per unit (in Dollars per share) Price Per Unit Price per unit. Outstanding shares, percentage Threshold Number Of Business Days To Redeem Public Shares From Combination Period "Represents the threshold number of business days to redeem Public Shares from Combination Period if the Company has not completed an Initial Business Combination. Redemption share percentage Redemption Share Percentage Redemption share percentage. Redemption, percentage Redemption Of Percentage Of Common Stock Included In Units Sold In Offering "Percentage of the total shares of Class A common stock sold in the Initial Public Offering that a Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a ""group"" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the ""Exchange Act"")), above which will be restricted from redeeming, without the prior consent of the Company. " Public Share [Member] Public Share Member Redeemed price per share Share Price Price per share (in Dollars per share) Purchase price per share (in Dollars per share) Shares Issued, Price Per Share Redeemed shares (in Shares) Stock Redeemed or Called During Period, Shares Aggregate amount Stock Redeemed or Called During Period, Value Sale of Stock [Axis] Redemption price (in Dollars per share) Temporary Equity, Redemption Price Per Share Summary of Significant Accounting Policies (Details) [Table] Founder Shares [Member] Founder Shares1 Member Business acquisition price (in Dollars per share) Business Combination, Price Per Share KVAC (Cayman) Limited (“Acquirer”) [Member] KVACCayman Limited Acquirer Member Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) [Table] Dividend income earned in investments held in Trust Account Investment Income, Interest and Dividend Total allocation to redeemable and non-redeemable ordinary shares Net Income (Loss) Available to Common Stockholders, Basic Numerators: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Total expenses Operating Expenses Exercised shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of shares issued per unit Number Of Shares Issued Per Unit Number of shares issued per unit. Denominators: Weighted Average Number of Shares Outstanding, Basic [Abstract] Initial Public Offering (Details) [Table] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Significant Other Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Recurring Basis [Member] Fair Value, Recurring [Member] Non- Redeemable Ordinary Share [Member] Non Redeemable Ordinary Share Member Redeemable Ordinary Share [Member] Redeemable Ordinary Share Member Percentage of issued and outstanding shares Percentage Of Issued And Outstanding Shares After Initial Public Offering Collectively Held By Initial Stockholders The expected ownership percentage by the founders after completion of the proposed public offering. Related Party Transactions (Details) [Table] Forecast [Member] Forecast [Member] Working capital deficit Working Capital Deficit The amount represents working capital deficit. Number of units (in Shares) Units Issued During Period Shares New Issued The share amount of new shares issued. Trust Account [Member] Transaction cost Transaction Cost Represents the amount of transaction cost. Cash equivalents Cash Equivalents, at Carrying Value Unrecognized tax benefits Unrecognized Tax Benefits, Beginning Balance Schedule Of Unaudited Condensed Consolidated Statements Of Income And Comprehensive Income Abstract Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) [Line Items] Related Party [Member] Related Party Related Party [Member] Related Party Transactions [Line Items] Aggregate purchase price Stock Issued During Period, Value, New Issues Redemption price of warrants or rights Class Of Warrant Or Right Redemption Price Of Warrants Or Rights Class of warrant or right, redemption price of warrants or rights. Ordinary per share equals or exceeds Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders Minimum threshold price of common stock specified to send notice of redemption to the warrant holders. Number of trading days after completion of business combination Number Of Trading Days After Completion Of Business Combination Represent the number of number of trading days after completion of business combination. Number of trading days starting prior date of consummation of business combination Number Of Trading Days Starting Prior Date Of Consummation Of Business Combination Represent the number of trading days starting prior date of consummation of business combination. Percentage of exercise price warrants Percentage Of Exercise Price Warrants Percentage of exercise price warrants. Issued and outstanding shares after the initial public offering Percentage Of Issued And Outstanding Shares Percentage of issued and outstanding shares. Accrued expenses Accrued Liabilities, Current TOTAL ASSETS Assets Total current assets Assets, Current Current assets: Assets, Current [Abstract] Cash at bank Cash and Cash Equivalent Commitments and contingencies (Note 7) Commitments and Contingencies Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share Units Each Consisting Of One Ordinary Share And One Redeemable Warrant To Acquire One Ordinary Share Member Warrants, each exercisable for one ordinary share at an exercise price of $11.50 Warrants Each Exercisable For One Ordinary Share At An Exercise Price Of1150 Member Ordinary Shares, $0.0001 par value Ordinary Shares00001 Par Value Member Prepayment Prepaid Expense, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Statement of Financial Position [Abstract] Ordinary shares, shares issued (in Shares) Ordinary share issued Common Stock, Shares, Issued Ordinary shares, shares outstanding (in Shares) Ordinary share outstanding Common Stock, Shares, Outstanding Shareholders’ Deficit: Equity, Attributable to Parent [Abstract] Subsequent Event [Member] Subsequent Event [Member] Minimum threshold written notice period for redemption of public warrants Class Of Warrant Or Right Minimum Threshold Written Notice Period For Redemption Of Warrants Represent the number of threshold days for written notice period for redemption of warrants. Number of threshold consecutive trading days for redemption of warrants Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days Represent the number of specified consecutive trading days for stock price trigger considered for redemption of warrants. Number of threshold trading days for redemption of warrants Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days Represent the number of specified trading days for stock price trigger considered for redemption of warrants. Document Fiscal Period Focus Common stock, voting rights Common Stock, Voting Rights Related Party Transaction [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Commitments and Contingencies [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Underwriting discount rate Underwriting Expense Ratio Chief Financial Officer Chief Executive Officer [Member] Title and Position [Axis] Title and Position [Domain] Operating segment Number of Operating Segments Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Description of segment Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Segment Information [Line Items] Segment Reporting Information [Line Items] Subsequent Events (Details) [Table] Subsequent Events [Line Items] Statement of Cash Flows [Abstract] Redemption of common stock Payments for Repurchase of Common Stock Extension payments deposited in Trust Account Payments to Acquire Investments RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Entity Current Reporting Status Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Interactive Data Current EX-101.PRE 11 kvac-20260331_pre.xml XBRL PRESENTATION FILE GRAPHIC 12 ea028941601_ex2-5img1.jpg GRAPHIC begin 644 ea028941601_ex2-5img1.jpg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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover - shares
3 Months Ended
Mar. 31, 2026
May 06, 2026
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2026  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Registrant Name KEEN VISION ACQUISITION CORPORATION  
Entity Central Index Key 0001889983  
Entity File Number 001-41753  
Entity Tax Identification Number 00-0000000  
Entity Incorporation, State or Country Code D8  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company true  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   5,506,521
Entity Address, Address Line One 37 Greenbriar Drive  
Entity Address, City or Town Summit  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07901  
City Area Code (203)  
Local Phone Number 609-1394  
Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share  
Trading Symbol KVACU  
Security Exchange Name NASDAQ  
Ordinary Shares, $0.0001 par value    
Document Information [Line Items]    
Title of 12(b) Security Ordinary Shares, $0.0001 par value  
Trading Symbol KVAC  
Security Exchange Name NASDAQ  
Warrants, each exercisable for one ordinary share at an exercise price of $11.50    
Document Information [Line Items]    
Title of 12(b) Security Warrants  
Trading Symbol KVACW  
Security Exchange Name NASDAQ  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash at bank $ 9,098 $ 11,206
Prepayment 95,225 25,550
Total current assets 104,323 36,756
Cash and investments held in trust account 13,153,709 57,003,115
TOTAL ASSETS 13,258,032 57,039,871
Current liabilities:    
Accrued expenses 106,907 73,496
Extension promissory note payable 2,788,022 2,668,022
Total current liabilities 4,477,809 4,057,398
Deferred underwriting compensation 2,990,000 2,990,000
TOTAL LIABILITIES 7,467,809 7,047,398
Commitments and contingencies (Note 7)
Ordinary shares, 4,822,346 and 14,950,000 shares subject to possible redemption issued and outstanding as of December 31, 2025 and 2024, respectively 13,153,709 57,003,115
Shareholders’ Deficit:    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of December 31, 2025 and 2024 (excluding 4,822,346 and 14,950,000 shares subject to possible redemption, respectively) 442 442
Accumulated deficit (7,363,928) (7,011,084)
Total Shareholders’ Deficit (7,363,486) (7,010,642)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT 13,258,032 57,039,871
Related Party    
Current liabilities:    
Amount due to a related party $ 1,582,880 $ 1,315,880
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Shares subject to possible redemption, shares issued (in Shares) 1,090,446 4,822,346
Shares subject to possible redemption, shares outstanding (in Shares) 1,090,446 4,822,346
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized (in Shares) 500,000,000 500,000,000
Ordinary shares, shares issued (in Shares) 4,416,075 4,416,075
Ordinary shares, shares outstanding (in Shares) 4,416,075 4,416,075
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Income - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Formation and operating costs $ (232,844) $ (171,333)
Other income:    
Dividend income earned in investments held in Trust Account 324,931 739,504
Total other income 324,931 739,504
NET INCOME $ 92,087 $ 568,171
Ordinary Shares Subject to Possible Redemption    
Other income:    
Basic weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) 3,163,724 6,404,652
Diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) 3,163,724 6,404,652
Basic net income per share, ordinary shares subject to possible redemption (in Dollars per share) $ 0.07 $ 0.1
Diluted net income per share, ordinary shares subject to possible redemption (in Dollars per share) $ 0.07 $ 0.1
Ordinary Shares Not Subject to Possible Redemption    
Other income:    
Basic weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) 4,416,075 4,416,075
Diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares) 4,416,075 4,416,075
Basic net income per share, ordinary shares subject to possible redemption (in Dollars per share) $ (0.03) $ (0.02)
Diluted net income per share, ordinary shares subject to possible redemption (in Dollars per share) $ (0.03) $ (0.02)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Ordinary shares
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 442 $ (4,199,554) $ (4,199,112)
Balance (in Shares) at Dec. 31, 2024 4,416,075    
Accretion of carrying value to redemption value (1,339,504) (1,339,504)
Net income 568,171 568,171
Balance at Mar. 31, 2025 $ 442 (4,970,887) (4,970,445)
Balance (in Shares) at Mar. 31, 2025 4,416,075    
Balance at Dec. 31, 2025 $ 442 (7,011,084) (7,010,642)
Balance (in Shares) at Dec. 31, 2025 4,416,075    
Accretion of carrying value to redemption value (444,931) (444,931)
Net income 92,087 92,087
Balance at Mar. 31, 2026 $ 442 $ (7,363,928) $ (7,363,486)
Balance (in Shares) at Mar. 31, 2026 4,416,075    
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income $ 92,087 $ 568,171
Adjustments to reconcile net income to net cash used in operating activities:    
Dividend income earned in cash and investments held in trust account (324,931) (739,504)
Changes in operating assets and liabilities:    
Prepayment (69,675) (62,860)
Accrued expenses 33,411 (74,013)
Net cash used in operating activities (269,108) (308,206)
Cash flows from investing activities:    
Extension payments deposited in Trust Account (120,000) (600,000)
Cash withdrawn from Trust Account in connection to redemption 44,294,337
Net cash provided by (used in) investing activities 44,174,337 (600,000)
Cash flows from financing activities:    
Advance from a related party 267,000 269,622
Proceed from extension promissory note payable - related party 120,000 600,000
Redemption of common stock (44,294,337)
Net cash provided by (used in) financing activities (43,907,337) 869,622
NET CHANGE IN CASH (2,108) (38,584)
CASH AT BANK, BEGINNING OF PERIOD 11,206 54,548
CASH AT BANK, END OF PERIOD 9,098 15,964
Non-cash investing and financing activities:    
Accretion of carrying value to redemption value $ 444,931 $ 1,339,504
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Organization and Business Background
3 Months Ended
Mar. 31, 2026
Organization and Business Background [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND

 

Keen Vision Acquisition Corporation (the “Company” or “we”, “us” and “our”) is a blank check company incorporated on June 18, 2021, under the laws of the British Virgin Islands for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination.

 

The Company is an early stage company and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage companies and emerging growth companies. The Company has selected December 31 as its fiscal year end.

 

As of March 31, 2026, the Company had not commenced any operations. All activities through March 31, 2026 relate to the Company’s formation, the initial public offering (the “Initial Public Offering” or “IPO”) and activities necessary to identify a potential target and prepare for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income and changes in unrealized appreciation of Trust Account assets from the proceeds derived from the Initial Public Offering.

 

Financing

 

The registration statement for the Company’s Initial Public Offering was declared effective on July 24, 2023. On July 27, 2023, the Company consummated the Initial Public Offering of 14,950,000 units (the “Public Units”), which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at $10.00 per Public Unit, generating gross proceeds of $149,500,000 to the Company. Each Public Unit consists of one ordinary share (“Public Share”) and one redeemable warrant (“Public Warrant”) to purchase one ordinary share at an exercise price of $11.50 per share.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 678,575 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to KVC Sponsor LLC (the “Sponsor”), generating gross proceeds of $6,785,750 to the Company. Each Private Placement Unit consists of one ordinary share (“Private Placement Share”) and one redeemable warrant (“Private Warrant”) to purchase one ordinary share at an exercise price of $11.50 per whole share.

 

Transaction costs amounted to $6,597,980, consisting of $2,990,000 of underwriting commissions, $2,990,000 of deferred underwriting commissions and $617,980 of other offering costs. In addition, at July 27, 2023, cash of $1,593,452 was held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. Cash of $151,368,750 was transferred to the Trust Account on July 27, 2023.

 

Trust Account

 

The aggregate amount of $151,368,750 ($10.125 per Public Unit) held in a trust account (“Trust Account”) established for the benefit of the Company’s public shareholders and maintained by Continental Stock Transfer & Trust Company, acting as trustee, will be invested only in U.S. government treasury bills, with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds in the Trust Account will not be released until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period) or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the redemption of all of the Company’s public shares if the Company is unable to complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period), subject to applicable law.

  

Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

 

The Company will provide its shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with an Initial Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company shall not consummate such Business Combination unless (i) the Company has net tangible assets of at least US$5,000,001 after payment of the deferred underwriting commissions, either immediately prior to, or upon such consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such Business Combination; or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from seeking redemption rights with respect to 15% or more of the public shares without the Company’s prior written consent.

 

If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 

The shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially $10.125 per public share, subject to increase of up to an additional $0.10 per public share per each three-month extension in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their public shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

 

The Company will proceed with a Business Combination if (i) the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended; and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 

The Sponsor and any of the Company’s officers or directors that may hold Founder Shares (as described in Note 5) (as defined the “initial shareholders”) are identical to the Public Shares except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below. The Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial business combination, with respect thereto, a vote to amend the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, or a tender offer by the Company prior to a Business Combination.

 

On March 22, 2024, the Company entered into a non-binding letter of intent (the “LOI”) with a business combination target (the “Target”), regarding a potential business combination involving the Target and its subsidiaries (the “Proposed Transaction”). The Target is a clinical stage biopharmaceutical company based in Boston, U.S., focusing on i) the research, development, manufacture and use of self-developed pioneering human stem cell-based bioengineering technology platform for novel drug discovery; and ii) the development of next-generation cell and gene therapies for a range of difficult-to-treat or incurable diseases. With a pipeline of therapeutic candidates, the Target’s several experimental gene therapies have already obtained U.S. Food and Drug Administration (“FDA”) Investigational New Drug (IND) approvals as ongoing clinical trials at multiple premier hospitals in the U.S. with active patient enrolments.

 

The LOI is non-binding and no agreement providing for any Proposed Transaction or any other transaction or the participation by either party therein will be deemed to exist unless and until definitive agreements have been executed. Pursuant to the IPO prospectus dated July 24, 2023, (Registration No. 333-269659) filed by the Company for the initial public offering (the “IPO”), the Company is entitled to an automatic six-month extension to complete a business combination (the “Automatic Extension Period”) after the execution of the LOI and has 15 months from the closing of its IPO, or October 27, 2024, to complete its initial business combination period.

 

On September 3, 2024, the Company has entered into merger agreement (“Merger Agreement”) with Medera Inc. (“Medera”). The Company will incorporate a Cayman Islands exempted company (“Acquirer”) to be a direct wholly-owned subsidiary of the Company for the purpose of the merger of Company with and into the Acquirer (the “Reincorporation Merger”), in which Acquirer will be the surviving entity. Acquirer upon its incorporation will form a Cayman Islands exempted company to be a direct wholly-owned subsidiary of Acquirer (“Merger Sub”) for the purpose of effectuating the Acquisition Merger. Upon the terms and subject to the conditions of the Merger Agreement, (a) The Company will reincorporate by merging with and into the Acquirer, in which the Acquirer will be the surviving company and the Company will cease to exist, and (b) promptly after the Reincorporation Merger, the parties intend to effect a merger of Merger Sub with and into Medera, in which Medera will be the surviving entity (the “Acquisition Merger”, together with the Reincorporation Merger, the “Mergers” and together with the other transactions related thereto, the “Proposed Business Combination”).

 

At the effective time of the Acquisition Merger, each outstanding Medera Ordinary Share (excluding treasury shares and dissenting shares) will be cancelled and converted into the right to receive a number of Acquirer Ordinary Shares equal to the Exchange Ratio, as outlined in the Merger Agreement. The number of Acquirer Ordinary Shares to be delivered by Acquirer to shareholders of Medera at the Closing is based on a net value of $622,560,000 for 100% of Medera’s issued and outstanding ordinary shares, with each Acquirer Ordinary Share valued at $10.00.

 

On October 25, 2024, in connection with the stockholders vote at the Annual Meeting, 8,545,348 shares were redeemed by certain shareholders at a price of approximately $10.81 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $92,398,989.

 

On October 25, 2024, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment”). Pursuant to the Trust Amendment, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement for a period of nine months from October 27, 2024 to July 27, 2025, by depositing into the Trust Account $200,000 for all remaining public shares (the “Extension Payment”) for each one-month extension.

 

The Company will have until July 27, 2025 (unless further extended) to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within nine months (the “Combination Period”), the Company may extend the period of time to consummate a Business Combination up to four times, each by an additional one month each time (for a total of 24 months including Automatic Extension Period) by depositing into the Trust Account $200,000 (approximately $0.10 per share per each month extension) to complete a Business Combination (the “Paid Extension Period”). Any funds which may be provided to extend the time frame will be in the form of a loan to the Company from the Sponsor. The terms of any such loan have not been definitively negotiated, provided, however, any loan will be interest free and will be repayable only if the Company completes a Business Combination.

 

On July 22, 2025, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment II”). Pursuant to the Trust Amendment II, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement II for a period of nine months from July 27, 2025 to January 27, 2026, by depositing into the Trust Account $0.03 for each remaining public shares (the “Extension Payment”) for each one-month extension.

 

On July 22, 2025, in connection with the stockholders vote at the Annual Meeting, 1,582,306 shares were redeemed by certain shareholders at a price of approximately $11.43 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $18,091,743.

 

On January 22, 2026, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer & Trust Company (the “Trust Amendment III”). Pursuant to the Trust Amendment III, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement III for a period of seven months from January 27, 2026 to July, 2026, by depositing into the Trust Account $120,000 for all remaining public shares (the “Extension Payment”) for each three-month extension.

 

On January 22, 2026, in connection with the stockholders’ vote at the Annual Meeting, 3,781,900 shares were redeemed by certain shareholders at a price of approximately $11.71 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $44,294,337.

 

On February 26, 2026, the Company entered into a binding letter of intent (“LOI”) with Medera and Novoheart Group Limited, a British Virgin Islands company and wholly owned subsidiary of Medera (“NVH”). The LOI replaces the prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI pursuant to a mutual release agreement entered into by the parties. In connection with the execution of the LOI, the parties also executed a standard termination and mutual release agreement relating to the current Merger Agreement between the Company and Medera.

 

As of the date of this report, the Company has extended seventeen times, and so it now has until July 27, 2026 to consummate a business combination. Pursuant to the terms of the current amended and restated memorandum and articles of association and the trust agreement between the Company and Continental Stock Transfer & Trust Company, LLC, in order to extend the time available for the Company to consummate the initial business combination, the Company’s insiders or their affiliates or designees, must deposit into the Trust Account $200,000 on or prior to the date of the applicable deadline. On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, respectively, the Company has deposited in an amount of $200,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, respectively, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026.

 

Liquidation

 

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price of $10.00 per Public Unit.

 

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.125 per share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and going concern

 

As of March 31, 2026, the Company reported a working capital deficit of $4,373,486. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company initially had nine months from the consummation of the Initial Public Offering to consummate the initial Business Combination. If the Company does not complete a Business Combination within nine months from the consummation of the Initial Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Act (As Revised) of the British Virgin Islands. Accordingly, no vote would be required from the shareholders to commence such a voluntary winding up, dissolution and liquidation. However, the Company may extend the period of time to consummate a Business Combination seventeen times (for a total of up to 36 months from the consummation of the Initial Public Offering to complete a Business Combination, including Automatic Extension Period). If the Company is unable to consummate the Company’s Initial Business Combination by July 27, 2026 (unless further extended), the Company will, as promptly as possible but not more than ten business days thereafter, redeem 100% of the Company’s outstanding public shares for a pro rata portion of the funds held in the Trust Account, including a pro rata portion of any interest earned on the funds held in the Trust Account and not necessary to pay taxes, and then seek to liquidate and dissolve. However, the Company may not be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of the Company’s public shareholders. In the event of dissolution and liquidation, the Company’s warrants will expire and will be worthless.

 

Additionally, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not consummated by July 27, 2026 (unless further extended). These unaudited condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

These accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all of the information and notes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2025 included in the Company’s Form 10-K filed with the SEC on March 25, 2026. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the unaudited condensed financial statements of the Company and its subsidiaries. All significant intercompany transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.

 

A subsidiary is the entity in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:

 

Name   Background   Ownership
KVAC (Cayman) Limited (“Acquirer”)   A Cayman Islands company
Incorporated on August 28, 2024
  100% owned by the Company
KVAC MS (Cayman) Limited   A Cayman Islands company
Incorporated on July 10, 2024
  100% owned by the Acquirer

 

Emerging growth company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2026 and December 31, 2025.

 

Cash and investment held in Trust Account

 

As of March 31, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. These securities are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividend income in the accompanying unaudited condensed consolidated statements of income and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets.

 

Warrant accounting

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.

 

As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.

 

Ordinary shares subject to possible redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of the Company’s control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively.

 

Fair value of financial instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. ASC 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judgment.

 

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by the market through correlation or other means.

 

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the unaudited condensed consolidated balance sheets. The fair values of cash and other current assets, accrued expenses, due to a related party are estimated to approximate the carrying values as of March 31, 2026 and December 31, 2025 due to the short maturities of such instruments.

  

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

    March 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2026     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 13,153,709     $ 13,153,709     $     -     $      -  

 

    December 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2025     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 57,003,115     $ 57,003,115     $      -     $      -  

 

Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited condensed consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the unaudited condensed consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s management determined that the British Virgin Islands and Cayman Islands are the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s tax provision was zero for the periods presented.

 

The Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands.

 

After the Initial Public Offering, the proceeds held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.

 

Net income (loss) per share

 

The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:

 

    For the Three Months Ended
March 31, 2026
    For the Three Months Ended
March 31, 2025
 
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
 
Basic and diluted net income (loss) per share:                        
Numerators:                        
Dividend income earned in investments held in Trust Account   $ 324,931     $ -     $ 739,504     $ -  
Total expenses     (97,186 )     (135,658 )     (101,410 )     (69,923 )
Total allocation to redeemable and non-redeemable ordinary shares   $ 227,745     $ (135,658 )   $ 638,094     $ (69,923 )
Denominators:                                
Weighted-average shares outstanding     3,163,724       4,416,075       6,404,652       4,416,075  
Basic and diluted net income (loss) per share   $ 0.07     $ (0.03 )   $ 0.10     $ (0.02 )

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.

 

Concentration of credit risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Recent issued accounting standards

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Initial Public Offering
3 Months Ended
Mar. 31, 2026
Initial Public Offering [Abstract]  
INITIAL PUBLIC OFFERING

NOTE 3 – INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering on July 27, 2023, the Company sold 14,950,000 Public Units, which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at a purchase price of $10.00 per Public Unit. Each Public Unit consists of one Public Share and one Public Warrant to purchase one ordinary share at an exercise price of $11.50 per share (see Note 6).

 

All of the 14,950,000 public shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

 

The Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.26.1
Private Placement
3 Months Ended
Mar. 31, 2026
Private Placement [Abstract]  
PRIVATE PLACEMENT

NOTE 4 – PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering on July 27, 2023, the Company consummated a private placement of 678,575 Private Placement Units, at a price of $10.00 per Private Placement Unit. Each Private Placement Unit consists of one Private Placement share and one Private Warrant to purchase one ordinary share at an exercise price of $11.50 per whole share.

 

The Private Placement Units are identical to the Public Units sold in the Initial Public Offering except for certain registration rights and transfer restrictions.

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.26.1
Related Party Transactions
3 Months Ended
Mar. 31, 2026
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Founder Shares

 

In September 2021, the Company issued an aggregate of 3,737,500 Founder Shares to the initial shareholders, including an aggregate of up to 487,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (see Note 6) for an aggregate purchase price of $25,000. As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (See Note 7).

 

Administrative Services Arrangement

 

An affiliate of the Sponsor agreed that, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, administrative and support services, as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $10,000 per month for these services commencing on the closing date of the Initial Public Offering for 15 months (or up to 21 months including Automatic Extension Period). As of March 31, 2026 and December 31, 2025, the unpaid services fee was $150,000 and $120,000, respectively, and is presented in amount due to a related party in the accompanying unaudited condensed consolidated balance sheets. For the three months ended March 31, 2026 and 2025, the Company incurred $30,000 and $30,000 in fees for these services, respectively.

 

Related Party Extensions Loan

 

The Company will have to consummate a Business Combination by July 27, 2026. However, if the Company anticipates that it may not be able to consummate a Business Combination within 21 months (including automatic extension period), the Company may extend the period of time to consummate a Business Combination up to four times, four times by an additional one month each time to complete a Business Combination. The Sponsor or its affiliates or designees will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the event that the Company are unable to close a Business Combination unless there are funds available outside the Trust Account to do so. Such notes would either be paid upon consummation of the initial Business Combination or at the lender’s discretion, converted upon consummation of the Business Combination into additional private units at a price of $10.00 per unit.

 

On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, the Company issued an unsecured promissory note in an amount of $200,000 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. The notes are non-interest bearing and are payable upon the closing of a business combination. In addition, the notes may be converted, at the lender’s discretion, into additional Private Units at a price of $10.00 per unit. As of March 31, 2026 and December 31, 2025, the note payable balance was $2,788,022 and $2,668,022, respectively.

  

Advance from a Related Party

 

As of March 31, 2026 and December 31, 2025, the Company had a temporary advance of $1,582,880 and $1,315,880 from the Sponsor, respectively. The balance is unsecured, interest-free and has no fixed terms of repayment. 

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Shareholders’ Deficit
3 Months Ended
Mar. 31, 2026
Shareholders’ Deficit [Abstract]  
SHAREHOLDERS’ DEFICIT

NOTE 6 – SHAREHOLDERS’ DEFICIT

 

Ordinary Shares

 

The Company is authorized to issue 500,000,000 ordinary shares at par $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share.

 

As of March 31, 2026 and December 31, 2025, 4,416,075 and 4,416,075 Ordinary Shares were issued and outstanding excluding 1,090,446 and 4,822,346 Ordinary Shares subject to possible redemption, respectively, so that the initial shareholders will own 20% of the issued and outstanding shares after the Initial Public Offering (excluding the sale of the Private Units and assuming the initial shareholders do not purchase any Units in the Initial Public Offering). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (see Note 7).

 

Warrants

 

Each holder of a warrant shall be entitled to purchase one ordinary share at an exercise price of $11.50. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable after the consummation of a Business Combination. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. The Company has agreed that as soon as practicable after the closing of a Business Combination, the Company will use its best efforts to file, and within 90 days following a Business Combination to have declared effective, a registration statement covering the ordinary shares issuable upon exercise of the warrants. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 90 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

 

The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant:

 

  upon not less than 30 days’ prior written notice of redemption to each warrant holder,

 

  if, and only if, the reported last sale price of the ordinary share equals or exceeds $16.5 per share, for any 20 trading days within a 30 trading days period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and

 

  if, and only if, there is a current registration statement in effect with respect to the issuance of the ordinary share underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

 

In addition, if in connection with a Business Combination, the Company (a) issues additional Ordinary Shares or equity-linked securities at an issue price or effective issue price of less than $9.35 per share (with such issue price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such issuance to the Company’s initial stockholders, or their affiliates, without taking into account any Founders’ Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions), and (c) the Fair Market Value (as defined below) is below $9.35 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (a) the Fair Market Value or (b) the price at which the Company issues the ordinary shares or equity-linked securities, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Fair Market Value and the price at which the Company issues ordinary shares or equity-linked securities. The “Fair Market Value” shall mean the volume weighted average reported trading price of the ordinary shares for the twenty (20) trading days starting on the trading day prior to the date of the consummation of the Business Combination.

 

The Private Warrants are identical to the Public Warrants underlying the Public Units being sold in the Initial Public Offering except that Private Placement Units will not be transferable, assignable or saleable until 30 days after the completion of the Company’s Business Combination and will be entitled to registration rights.

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the Russia-Ukraine war and the conflict in Israel and Palestine on the industry and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on July 24, 2023, the holders of the Founder Shares, Private Placement Units (including securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital loans or extension loans and are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriter Agreement

 

The underwriters are entitled to a cash underwriting discount of 2% of the gross proceeds of the Initial Public Offering, or $2,990,000, upon the closing of the Business Combination, which is shown as deferred underwriting expenses on the accompanying unaudited condensed consolidated balance sheets.

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information
3 Months Ended
Mar. 31, 2026
Segment Information [Abstract]  
SEGMENT INFORMATION

NOTE 8 – SEGMENT INFORMATION

 

ASC Topic 280, Segment Reporting, establishes standards for companies to report in their unaudited condensed financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which includes formation and operating costs and interest and dividend earned on investments held in Trust Account which are included in the accompanying statements of income.

 

The key measures of segment profit or loss reviewed by the CODM are earned on investments held in Trust Account and formation and operating costs. The CODM reviewed earned on investments held in Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Subsequent Events
3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the unaudited condensed consolidated balance sheet date, the Company has evaluated all events or transactions that occurred after the unaudited condensed consolidated balance sheet date.

 

On April 27, 2026 the Company issued an unsecured promissory note in an amount of $120,000 to the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026.

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Pay vs Performance Disclosure    
Net Income (Loss) $ 92,087 $ 568,171
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation

 

These accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all of the information and notes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2025 included in the Company’s Form 10-K filed with the SEC on March 25, 2026. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

Principles of consolidation
Principles of consolidation

 

The unaudited condensed consolidated financial statements include the unaudited condensed financial statements of the Company and its subsidiaries. All significant intercompany transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.

 

A subsidiary is the entity in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:

 

Name   Background   Ownership
KVAC (Cayman) Limited (“Acquirer”)   A Cayman Islands company
Incorporated on August 28, 2024
  100% owned by the Company
KVAC MS (Cayman) Limited   A Cayman Islands company
Incorporated on July 10, 2024
  100% owned by the Acquirer
Emerging growth company
Emerging growth company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of estimates
Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash
Cash

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2026 and December 31, 2025.

Cash and investment held in trust account
Cash and investment held in Trust Account

 

As of March 31, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. These securities are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividend income in the accompanying unaudited condensed consolidated statements of income and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets.

Warrant accounting
Warrant accounting

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.

 

As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.

Ordinary shares subject to possible redemption
Ordinary shares subject to possible redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of the Company’s control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively.

Fair value of financial instruments
Fair value of financial instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. ASC 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judgment.

 

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by the market through correlation or other means.

 

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the unaudited condensed consolidated balance sheets. The fair values of cash and other current assets, accrued expenses, due to a related party are estimated to approximate the carrying values as of March 31, 2026 and December 31, 2025 due to the short maturities of such instruments.

  

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

    March 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2026     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 13,153,709     $ 13,153,709     $     -     $      -  

 

    December 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2025     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 57,003,115     $ 57,003,115     $      -     $      -  
Income taxes
Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited condensed consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the unaudited condensed consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s management determined that the British Virgin Islands and Cayman Islands are the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s tax provision was zero for the periods presented.

 

The Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands.

 

After the Initial Public Offering, the proceeds held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.

Net income (loss) per share
Net income (loss) per share

 

The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:

 

    For the Three Months Ended
March 31, 2026
    For the Three Months Ended
March 31, 2025
 
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
 
Basic and diluted net income (loss) per share:                        
Numerators:                        
Dividend income earned in investments held in Trust Account   $ 324,931     $ -     $ 739,504     $ -  
Total expenses     (97,186 )     (135,658 )     (101,410 )     (69,923 )
Total allocation to redeemable and non-redeemable ordinary shares   $ 227,745     $ (135,658 )   $ 638,094     $ (69,923 )
Denominators:                                
Weighted-average shares outstanding     3,163,724       4,416,075       6,404,652       4,416,075  
Basic and diluted net income (loss) per share   $ 0.07     $ (0.03 )   $ 0.10     $ (0.02 )
Related parties
Related parties

 

Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.

Concentration of credit risk
Concentration of credit risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent issued accounting standards
Recent issued accounting standards

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Consolidated Financial Statements

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:

 

Name   Background   Ownership
KVAC (Cayman) Limited (“Acquirer”)   A Cayman Islands company
Incorporated on August 28, 2024
  100% owned by the Company
KVAC MS (Cayman) Limited   A Cayman Islands company
Incorporated on July 10, 2024
  100% owned by the Acquirer
Schedule of Fair Value Hierarchy of the Valuation Techniques

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

    March 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2026     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 13,153,709     $ 13,153,709     $     -     $      -  
    December 31,     Quoted
Prices In
Active
Markets
    Significant
Other
Observable
Inputs
    Significant
Other
Unobservable
Inputs
 
Description   2025     (Level 1)     (Level 2)     (Level 3)  
Assets:                        
U.S. Treasury Securities held in Trust Account   $ 57,003,115     $ 57,003,115     $      -     $      -  
Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income

The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:

 

    For the Three Months Ended
March 31, 2026
    For the Three Months Ended
March 31, 2025
 
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
    Redeemable
Ordinary
Share
    Non-
Redeemable
Ordinary
Share
 
Basic and diluted net income (loss) per share:                        
Numerators:                        
Dividend income earned in investments held in Trust Account   $ 324,931     $ -     $ 739,504     $ -  
Total expenses     (97,186 )     (135,658 )     (101,410 )     (69,923 )
Total allocation to redeemable and non-redeemable ordinary shares   $ 227,745     $ (135,658 )   $ 638,094     $ (69,923 )
Denominators:                                
Weighted-average shares outstanding     3,163,724       4,416,075       6,404,652       4,416,075  
Basic and diluted net income (loss) per share   $ 0.07     $ (0.03 )   $ 0.10     $ (0.02 )
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Organization and Business Background (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Jan. 22, 2026
Jul. 22, 2025
Oct. 25, 2024
Jul. 27, 2023
Mar. 31, 2026
Jul. 27, 2026
Jul. 27, 2025
Apr. 27, 2026
Jan. 27, 2026
Jan. 26, 2026
Dec. 31, 2025
Dec. 19, 2025
Nov. 18, 2025
Oct. 21, 2025
Sep. 19, 2025
Aug. 18, 2025
Jul. 23, 2025
Jun. 23, 2025
May 20, 2025
Apr. 25, 2025
Mar. 24, 2025
Feb. 24, 2025
Jan. 22, 2025
Dec. 23, 2024
Nov. 20, 2024
Oct. 28, 2024
Organization and Business Background [Line Items]                                                    
Purchase price per unit (in Dollars per share)         $ 10.125                                          
Transaction cost         $ 6,597,980                                          
Underwriting commissions         2,990,000                                          
Deferred underwriting commissions         2,990,000           $ 2,990,000                              
Other offering costs         $ 617,980                                          
Cash transferred to trust account       $ 151,368,750                                            
Maturity period         185 years                                          
Percentage of aggregate fair market value         80.00%                                          
Net tangible assets         $ 5,000,001                                          
Redemption, percentage         15.00%                                          
Price per share (in Dollars per share)         $ 10                                          
Closing net value         $ 622,560,000                                          
Percentage of issued and outstanding ordinary shares         100.00%                                          
Redeemed shares (in Shares) 3,781,900 1,582,306 8,545,348                                              
Redemption price (in Dollars per share)   $ 11.43 $ 10.81                                              
Deposit amount             $ 200,000                                      
Outstanding public shares, percentage         100.00%                                          
Dissolution expenses         $ 50,000                                          
Working capital deficit         $ 4,373,486                                          
Redeemed price per share $ 11.71                                                  
Aggregate amount $ 44,294,337                                                  
Trust Account [Member]                                                    
Organization and Business Background [Line Items]                                                    
Depositing amount to trust account             200,000                                      
Forecast [Member]                                                    
Organization and Business Background [Line Items]                                                    
Depositing amount to trust account           $ 120,000                                        
Public Warrant [Member]                                                    
Organization and Business Background [Line Items]                                                    
Purchase of each warrant (in Shares)       1                                            
Exercise price (in Dollars per share)       $ 11.5                                            
Private Warrants [Member]                                                    
Organization and Business Background [Line Items]                                                    
Purchase of each warrant (in Shares)       1 1                                          
Common Stock [Member]                                                    
Organization and Business Background [Line Items]                                                    
Aggregate amount   $ 18,091,743 $ 92,398,989                                              
Sponsor [Member]                                                    
Organization and Business Background [Line Items]                                                    
Cash held outside trust account                   $ 120,000   $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670                  
Price per share (in Dollars per share)         $ 0.1                                          
Business Combination [Member]                                                    
Organization and Business Background [Line Items]                                                    
Cash held outside trust account             $ 200,000   $ 144,670 $ 120,000   $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000
Voting securities, percentage         50.00%                                          
Net tangible assets         $ 5,000,001                                          
Price per share (in Dollars per share)   $ 0.03         $ 0.1                                      
Deposit         $ 200,000                                          
Outstanding shares, percentage         100.00%                                          
Business Combination [Member] | Forecast [Member]                                                    
Organization and Business Background [Line Items]                                                    
Cash held outside trust account               $ 120,000                                    
Initial Public Offering [Member]                                                    
Organization and Business Background [Line Items]                                                    
Number of units (in Shares)       14,950,000                                            
Purchase price per unit (in Dollars per share)         $ 10                                          
Gross proceeds       $ 149,500,000                                            
Company consummated sale (in Shares)       14,950,000 14,950,000                                          
Cash held outside trust account       $ 1,593,452                                            
Redemption share percentage         100.00%                                          
Initial Public Offering [Member] | Public Warrant [Member]                                                    
Organization and Business Background [Line Items]                                                    
Purchase of each warrant (in Shares)       1                                            
Exercise price (in Dollars per share)       $ 11.5                                            
Over-Allotment Option [Member]                                                    
Organization and Business Background [Line Items]                                                    
Number of units (in Shares)       1,950,000                                            
Purchase price per unit (in Dollars per share)       $ 10                                            
Price per share (in Dollars per share)       10                                            
Private Placement [Member]                                                    
Organization and Business Background [Line Items]                                                    
Purchase price per unit (in Dollars per share)       10 $ 10                                          
Exercise price (in Dollars per share)       $ 11.5 $ 11.5                                          
Company consummated sale (in Shares)       678,575 678,575                                          
Gross proceeds from private         $ 6,785,750                                          
Public Share [Member]                                                    
Organization and Business Background [Line Items]                                                    
Aggregate of held in trust account         $ 151,368,750                                          
Price per share (in Dollars per share)         $ 10.125                                          
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Summary of Significant Accounting Policies [Line Items]    
Cash equivalents
Ordinary shares subject to possible redemption 1,090,446 4,822,346
Unrecognized tax benefits
Accrued for interest and penalties
Private Warrants [Member]    
Summary of Significant Accounting Policies [Line Items]    
Warrants to purchase aggregate shares 15,628,575 15,628,575
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details)
3 Months Ended
Mar. 31, 2026
KVAC (Cayman) Limited (“Acquirer”) [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Background A Cayman Islands company Incorporated on August 28, 2024
Ownership 100.00%
KVAC MS (Cayman) Limited [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Background A Cayman Islands company Incorporated on July 10, 2024
Ownership 100.00%
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Assets:    
U.S. Treasury Securities held in Trust Account $ 13,153,709 $ 57,003,115
Recurring Basis [Member]    
Assets:    
U.S. Treasury Securities held in Trust Account 13,153,709 57,003,115
Quoted Prices In Active Markets (Level 1) [Member] | Recurring Basis [Member]    
Assets:    
U.S. Treasury Securities held in Trust Account 13,153,709 57,003,115
Significant Other Observable Inputs (Level 2) [Member] | Recurring Basis [Member]    
Assets:    
U.S. Treasury Securities held in Trust Account
Significant Other Unobservable Inputs (Level 3) [Member] | Recurring Basis [Member]    
Assets:    
U.S. Treasury Securities held in Trust Account
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2024
Redeemable Ordinary Share [Member]    
Numerators:    
Dividend income earned in investments held in Trust Account $ 324,931 $ 739,504
Total expenses (97,186) (101,410)
Total allocation to redeemable and non-redeemable ordinary shares $ 227,745 $ 638,094
Denominators:    
Weighted-average shares outstanding (in Shares) 3,163,724 6,404,652
Basic net income (loss) per share (in Dollars per share) $ 0.07 $ 0.1
Diluted net income (loss) per share (in Dollars per share) $ 0.07 $ 0.1
Non- Redeemable Ordinary Share [Member]    
Numerators:    
Dividend income earned in investments held in Trust Account
Total expenses (135,658) (69,923)
Total allocation to redeemable and non-redeemable ordinary shares $ (135,658) $ (69,923)
Denominators:    
Weighted-average shares outstanding (in Shares) 4,416,075 4,416,075
Basic net income (loss) per share (in Dollars per share) $ (0.03) $ (0.02)
Diluted net income (loss) per share (in Dollars per share) $ (0.03) $ (0.02)
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Initial Public Offering (Details) - $ / shares
Jul. 27, 2023
Mar. 31, 2026
Initial Public Offering [Line Items]    
Purchase price per share (in Dollars per share)   $ 10
Public Warrant [Member]    
Initial Public Offering [Line Items]    
Number of shares issued per unit 1  
Purchase of each warrant 1  
Exercise price per share (in Dollars per share) $ 11.5  
Initial Public Offering [Member]    
Initial Public Offering [Line Items]    
Sale of public units 14,950,000 14,950,000
Initial Public Offering [Member] | Public Warrant [Member]    
Initial Public Offering [Line Items]    
Exercised shares 1,950,000  
Purchase of each warrant 1  
Exercise price per share (in Dollars per share) $ 11.5  
Over-Allotment Option [Member]    
Initial Public Offering [Line Items]    
Purchase price per share (in Dollars per share) $ 10  
Public Share [Member]    
Initial Public Offering [Line Items]    
Purchase price per share (in Dollars per share)   $ 10.125
Number of shares issued per unit 1  
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Private Placement (Details) - $ / shares
Jul. 27, 2023
Mar. 31, 2026
Private Placement [Line Items]    
Price per unit (in Dollars per share)   $ 10.125
Private Warrants [Member]    
Private Placement [Line Items]    
Number of shares issued per unit 1  
Purchase of each warrant 1 1
Private Placement [Member]    
Private Placement [Line Items]    
Number of units 678,575 678,575
Price per unit (in Dollars per share) $ 10 $ 10
Number of shares issued per unit 1  
Exercise price (in Dollars per share) $ 11.5 $ 11.5
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Related Party Transactions (Details) - USD ($)
3 Months Ended
Apr. 27, 2026
Jun. 23, 2025
May 20, 2025
Apr. 25, 2025
Mar. 24, 2025
Feb. 24, 2025
Jan. 22, 2025
Dec. 23, 2024
Nov. 20, 2024
Oct. 28, 2024
Sep. 30, 2021
Mar. 31, 2026
Mar. 31, 2025
Jan. 27, 2026
Jan. 26, 2026
Dec. 31, 2025
Dec. 19, 2025
Nov. 18, 2025
Oct. 21, 2025
Sep. 19, 2025
Aug. 18, 2025
Jul. 27, 2025
Jul. 23, 2025
Jul. 27, 2023
Related Party Transactions [Line Items]                                                
Percentage of issued and outstanding shares                     20.00%                          
Payment for month rent                       $ 10,000                        
Services fee                       150,000       $ 120,000                
Fees incurred                       30,000 $ 30,000                      
Note payable                       $ 2,788,022       2,668,022                
Business Combination [Member]                                                
Related Party Transactions [Line Items]                                                
Business acquisition price (in Dollars per share)                       $ 10                        
Deposited into the trust account   $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000       $ 144,670 $ 120,000   $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 200,000 $ 144,670  
Founder Shares [Member]                                                
Related Party Transactions [Line Items]                                                
Aggregate shares (in Shares)                     3,737,500                          
Shares subject to forfeiture (in Shares)                     487,500                          
Sponsor [Member]                                                
Related Party Transactions [Line Items]                                                
Issued an unsecured promissory note   $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000 $ 200,000                            
Deposited into the trust account                             $ 120,000   $ 144,670 $ 144,670 $ 144,670 $ 144,670 $ 144,670   $ 144,670  
Related Party [Member]                                                
Related Party Transactions [Line Items]                                                
Price per unit (in Dollars per share)                       $ 10                        
Temporary advance                       $ 1,582,880       $ 1,315,880                
Subsequent Event [Member]                                                
Related Party Transactions [Line Items]                                                
Issued an unsecured promissory note $ 120,000                                              
Subsequent Event [Member] | Sponsor [Member]                                                
Related Party Transactions [Line Items]                                                
Deposited into the trust account $ 120,000                                              
Initial Public Offering [Member]                                                
Related Party Transactions [Line Items]                                                
Deposited into the trust account                                               $ 1,593,452
Initial Public Offering [Member] | Founder Shares [Member]                                                
Related Party Transactions [Line Items]                                                
Aggregate purchase price                     $ 25,000                          
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Shareholders’ Deficit (Details) - $ / shares
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Jul. 27, 2023
Shareholders’ Deficit [Line Items]      
Ordinary shares, shares authorized 500,000,000 500,000,000  
Ordinary shares, par value $ 0.0001 $ 0.0001  
Common stock, voting rights one    
Ordinary share issued 4,416,075 4,416,075  
Ordinary share outstanding 4,416,075 4,416,075  
Ordinary shares subject to possible redemption issued 1,090,446 4,822,346  
Ordinary shares subject to possible redemption outstanding 1,090,446 4,822,346  
Threshold period for effective within statement after business combination 90 days    
Threshold period for not effective within statement after business combination 90 days    
Warrants term 5 years    
Redemption price of warrants or rights $ 0.01    
Minimum threshold written notice period for redemption of public warrants 30 days    
Number of threshold consecutive trading days for redemption of warrants 3 days    
Percentage of exercise price warrants 115.00%    
Redemption trigger price $ 16.5    
Percentage of market value 165.00%    
Number of trading days starting prior date of consummation of business combination 20 days    
Number of trading days after completion of business combination 30 days    
Warrant [Member]      
Shareholders’ Deficit [Line Items]      
Purchase of each warrant 1    
Exercise price $ 11.5    
Effective issue price per share $ 9.35    
Aggregate gross proceeds percentage 60.00%    
Price threshold fair market value of exercise of warrants $ 9.35    
Public Warrant [Member]      
Shareholders’ Deficit [Line Items]      
Purchase of each warrant     1
Exercise price     $ 11.5
Ordinary per share equals or exceeds $ 16.5    
Number of threshold trading days for redemption of warrants 20 days    
Number of threshold consecutive trading days for redemption of warrants 30 days    
Founder Shares [Member]      
Shareholders’ Deficit [Line Items]      
Issued and outstanding shares after the initial public offering 20.00%    
Common Stock [Member]      
Shareholders’ Deficit [Line Items]      
Ordinary shares subject to possible redemption issued 1,090,446    
Ordinary shares subject to possible redemption outstanding   4,822,346  
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Commitments and Contingencies [Line Items]    
Deferred underwriting expenses $ 2,990,000 $ 2,990,000
Underwriter Agreement [Member]    
Commitments and Contingencies [Line Items]    
Underwriting discount rate 2.00%  
Deferred underwriting expenses $ 2,990,000  
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information (Details)
3 Months Ended
Mar. 31, 2026
Segment
Segment Information [Line Items]  
Description of segment The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.
Operating segment 1
Chief Financial Officer  
Segment Information [Line Items]  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Chief Financial Officer
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Subsequent Events (Details)
Apr. 27, 2026
USD ($)
Subsequent Event [Member]  
Subsequent Events [Line Items]  
Unsecured promissory note $ 120,000
XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 124 183 1 false 32 0 false 5 false false R1.htm 995300 - Document - Cover Sheet http://kvac.com/20260331/role/Cover Cover Cover 1 false false R2.htm 995301 - Statement - Condensed Consolidated Balance Sheets Sheet http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 995302 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 995303 - Statement - Unaudited Condensed Consolidated Statements of Income Sheet http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome Unaudited Condensed Consolidated Statements of Income Statements 4 false false R5.htm 995304 - Statement - Unaudited Condensed Consolidated Statements of Changes in Shareholders??? Deficit Sheet http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit Unaudited Condensed Consolidated Statements of Changes in Shareholders??? Deficit Statements 5 false false R6.htm 995305 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows Unaudited Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995306 - Disclosure - Organization and Business Background Sheet http://kvac.com/20260331/role/OrganizationandBusinessBackground Organization and Business Background Notes 7 false false R8.htm 995307 - Disclosure - Summary of Significant Accounting Policies Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 995308 - Disclosure - Initial Public Offering Sheet http://kvac.com/20260331/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 995309 - Disclosure - Private Placement Sheet http://kvac.com/20260331/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 995310 - Disclosure - Related Party Transactions Sheet http://kvac.com/20260331/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 995311 - Disclosure - Shareholders??? Deficit Sheet http://kvac.com/20260331/role/ShareholdersDeficit Shareholders??? Deficit Notes 12 false false R13.htm 995312 - Disclosure - Commitments and Contingencies Sheet http://kvac.com/20260331/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 995313 - Disclosure - Segment Information Sheet http://kvac.com/20260331/role/SegmentInformation Segment Information Notes 14 false false R15.htm 995314 - Disclosure - Subsequent Events Sheet http://kvac.com/20260331/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 16 false false R17.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 17 false false R18.htm 996315 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://kvac.com/20260331/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 996316 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://kvac.com/20260331/role/SummaryofSignificantAccountingPolicies 19 false false R20.htm 996317 - Disclosure - Organization and Business Background (Details) Sheet http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails Organization and Business Background (Details) Details http://kvac.com/20260331/role/OrganizationandBusinessBackground 20 false false R21.htm 996318 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables 21 false false R22.htm 996319 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details) Details 22 false false R23.htm 996320 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) Details 23 false false R24.htm 996321 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) Sheet http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) Details 24 false false R25.htm 996322 - Disclosure - Initial Public Offering (Details) Sheet http://kvac.com/20260331/role/InitialPublicOfferingDetails Initial Public Offering (Details) Details http://kvac.com/20260331/role/InitialPublicOffering 25 false false R26.htm 996323 - Disclosure - Private Placement (Details) Sheet http://kvac.com/20260331/role/PrivatePlacementDetails Private Placement (Details) Details http://kvac.com/20260331/role/PrivatePlacement 26 false false R27.htm 996324 - Disclosure - Related Party Transactions (Details) Sheet http://kvac.com/20260331/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://kvac.com/20260331/role/RelatedPartyTransactions 27 false false R28.htm 996325 - Disclosure - Shareholders??? Deficit (Details) Sheet http://kvac.com/20260331/role/ShareholdersDeficitDetails Shareholders??? Deficit (Details) Details http://kvac.com/20260331/role/ShareholdersDeficit 28 false false R29.htm 996326 - Disclosure - Commitments and Contingencies (Details) Sheet http://kvac.com/20260331/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://kvac.com/20260331/role/CommitmentsandContingencies 29 false false R30.htm 996327 - Disclosure - Segment Information (Details) Sheet http://kvac.com/20260331/role/SegmentInformationDetails Segment Information (Details) Details http://kvac.com/20260331/role/SegmentInformation 30 false false R31.htm 996328 - Disclosure - Subsequent Events (Details) Sheet http://kvac.com/20260331/role/SubsequentEventsDetails Subsequent Events (Details) Details http://kvac.com/20260331/role/SubsequentEvents 31 false false All Reports Book All Reports ea0289416-10q_keen.htm kvac-20260331.xsd kvac-20260331_cal.xml kvac-20260331_def.xml kvac-20260331_lab.xml kvac-20260331_pre.xml http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0289416-10q_keen.htm": { "nsprefix": "kvac", "nsuri": "http://kvac.com/20260331", "dts": { "inline": { "local": [ "ea0289416-10q_keen.htm" ] }, "schema": { "local": [ "kvac-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd", "https://xbrl.sec.gov/country/2026/country-2026.xsd", "https://xbrl.sec.gov/dei/2026/dei-2026.xsd", "https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd", "https://xbrl.sec.gov/ecd/2026/ecd-sub-2026.xsd", "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd" ] }, "calculationLink": { "local": [ "kvac-20260331_cal.xml" ] }, "definitionLink": { "local": [ "kvac-20260331_def.xml" ] }, "labelLink": { "local": [ "kvac-20260331_lab.xml" ] }, "presentationLink": { "local": [ "kvac-20260331_pre.xml" ] } }, "keyStandard": 138, "keyCustom": 45, "axisStandard": 15, "axisCustom": 0, "memberStandard": 15, "memberCustom": 16, "hidden": { "total": 27, "http://xbrl.sec.gov/dei/2026": 5, "http://fasb.org/us-gaap/2026": 20, "http://kvac.com/20260331": 2 }, "contextCount": 124, "entityCount": 1, "segmentCount": 32, "elementCount": 405, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2026": 292, "http://xbrl.sec.gov/dei/2026": 36, "http://xbrl.sec.gov/ecd/2026": 4 }, "report": { "R1": { "role": "http://kvac.com/20260331/role/Cover", "longName": "995300 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "cref_1120094474", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R2": { "role": "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "longName": "995301 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R3": { "role": "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:TemporaryEquitySharesIssued", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome", "longName": "995303 - Statement - Unaudited Condensed Consolidated Statements of Income", "shortName": "Unaudited Condensed Consolidated Statements of Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R5": { "role": "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit", "longName": "995304 - Statement - Unaudited Condensed Consolidated Statements of Changes in Shareholders\u2019 Deficit", "shortName": "Unaudited Condensed Consolidated Statements of Changes in Shareholders\u2019 Deficit", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "cref_1958070949", "name": "us-gaap:StockholdersEquity", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1958070949", "name": "us-gaap:StockholdersEquity", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R6": { "role": "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows", "longName": "995305 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows", "shortName": "Unaudited Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:NetIncomeLoss", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R7": { "role": "http://kvac.com/20260331/role/OrganizationandBusinessBackground", "longName": "995306 - Disclosure - Organization and Business Background", "shortName": "Organization and Business Background", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R8": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPolicies", "longName": "995307 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R9": { "role": "http://kvac.com/20260331/role/InitialPublicOffering", "longName": "995308 - Disclosure - Initial Public Offering", "shortName": "Initial Public Offering", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "cref_1120094474", "name": "kvac:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "kvac:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R10": { "role": "http://kvac.com/20260331/role/PrivatePlacement", "longName": "995309 - Disclosure - Private Placement", "shortName": "Private Placement", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "cref_1120094474", "name": "kvac:PrivatePlacementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "kvac:PrivatePlacementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R11": { "role": "http://kvac.com/20260331/role/RelatedPartyTransactions", "longName": "995310 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R12": { "role": "http://kvac.com/20260331/role/ShareholdersDeficit", "longName": "995311 - Disclosure - Shareholders\u2019 Deficit", "shortName": "Shareholders\u2019 Deficit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R13": { "role": "http://kvac.com/20260331/role/CommitmentsandContingencies", "longName": "995312 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R14": { "role": "http://kvac.com/20260331/role/SegmentInformation", "longName": "995313 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R15": { "role": "http://kvac.com/20260331/role/SubsequentEvents", "longName": "995314 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R16": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:NetIncomeLoss", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": null }, "R17": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "cref_1120094474", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R18": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies", "longName": "996315 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "18", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:BasisOfAccounting", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:BasisOfAccounting", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R19": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables", "longName": "996316 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R20": { "role": "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "longName": "996317 - Disclosure - Organization and Business Background (Details)", "shortName": "Organization and Business Background (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "cref_1193296626", "name": "kvac:PricePerUnit", "unitRef": "uref_2066964847", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "kvac:TransactionCost", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R21": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "996318 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:TemporaryEquitySharesOutstanding", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:TemporaryEquitySharesIssued", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1628093681", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R22": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails", "longName": "996319 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Consolidated Financial Statements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "cref_403502956", "name": "us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_403502956", "name": "us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R23": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails", "longName": "996320 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_344408043", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R24": { "role": "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "longName": "996321 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "cref_543362496", "name": "us-gaap:InvestmentIncomeInterestAndDividend", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_543362496", "name": "us-gaap:InvestmentIncomeInterestAndDividend", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R25": { "role": "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "longName": "996322 - Disclosure - Initial Public Offering (Details)", "shortName": "Initial Public Offering (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "uref_2066964847", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1605372381", "name": "kvac:NumberOfSharesIssuedPerUnit", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "kvac:InitialPublicOfferingTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R26": { "role": "http://kvac.com/20260331/role/PrivatePlacementDetails", "longName": "996323 - Disclosure - Private Placement (Details)", "shortName": "Private Placement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "cref_1193296626", "name": "kvac:PricePerUnit", "unitRef": "uref_2066964847", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_699882517", "name": "kvac:NumberOfSharesIssuedPerUnit", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "kvac:PrivatePlacementsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R27": { "role": "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "longName": "996324 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "cref_1408142256", "name": "kvac:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "unitRef": "uref_1150944870", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1408142256", "name": "kvac:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "unitRef": "uref_1150944870", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R28": { "role": "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "longName": "996325 - Disclosure - Shareholders\u2019 Deficit (Details)", "shortName": "Shareholders\u2019 Deficit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "uref_919194553", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:CommonStockVotingRights", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R29": { "role": "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails", "longName": "996326 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "cref_1193296626", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": { "contextRef": "cref_1150944870", "name": "us-gaap:UnderwritingExpenseRatio", "unitRef": "uref_1150944870", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "unique": true } }, "R30": { "role": "http://kvac.com/20260331/role/SegmentInformationDetails", "longName": "996327 - Disclosure - Segment Information (Details)", "shortName": "Segment Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "cref_1120094474", "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true, "unique": true } }, "R31": { "role": "http://kvac.com/20260331/role/SubsequentEventsDetails", "longName": "996328 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "cref_1874302664", "name": "us-gaap:ProceedsFromUnsecuredNotesPayable", "unitRef": "uref_1874302664", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ea0289416-10q_keen.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r774" ] }, "kvac_AccruedUnderwritingCompensations": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "AccruedUnderwritingCompensations", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion of carrying value to redemption value", "label": "Accrued Underwriting Compensations", "documentation": "It represents the amount of accrued underwriting compensation." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r712" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r725" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r725" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r725" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r725" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "kvac_AggregateOfHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "AggregateOfHeldInTrustAccount", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate of held in trust account", "label": "Aggregate Of Held In Trust Account", "documentation": "Aggregate of held in trust account." } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r758" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r684", "r694", "r704", "r736" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r687", "r697", "r707", "r739" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r759" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r725" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r732" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r688", "r698", "r708", "r732", "r740", "r744", "r752" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r750" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentFlag", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r389" ] }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetAcquisitionConsiderationTransferred", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash transferred to trust account", "label": "Asset Acquisition, Consideration Transferred", "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer." } } }, "auth_ref": [ "r656", "r847", "r848", "r849" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Assets", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r30", "r31", "r38", "r74", "r75", "r76", "r112", "r126", "r145", "r149", "r156", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r239", "r390", "r392", "r448", "r481", "r482", "r483", "r497", "r498", "r502", "r570", "r633", "r634", "r642", "r662", "r663", "r664", "r675", "r799", "r800", "r861" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsAbstract", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Assets:", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r30", "r31", "r56", "r74", "r75", "r76", "r156", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r239", "r390", "r392", "r448", "r662", "r768", "r799", "r800", "r861" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsCurrentAbstract", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsHeldInTrust", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash held outside trust account", "verboseLabel": "Deposited into the trust account", "label": "Asset, Held-in-Trust", "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations." } } }, "auth_ref": [ "r781", "r782", "r864" ] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "U.S. Treasury Securities held in Trust Account", "terseLabel": "Cash and investments held in trust account", "label": "Asset, Held-in-Trust, Noncurrent", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r781", "r782", "r864" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r747" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r748" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r743" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r743" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r743" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r743" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r743" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r743" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r746" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r745" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r744" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r744" ] }, "us-gaap_BasisOfAccounting": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BasisOfAccounting", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of presentation", "label": "Basis of Accounting [Text Block]", "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r780" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination [Domain]", "documentation": "Business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r167", "r168", "r169", "r170", "r171", "r172", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r525", "r615", "r649", "r650", "r840", "r843", "r844" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r167", "r168", "r169", "r170", "r171", "r172", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r525", "r615", "r649", "r650", "r840", "r843", "r844" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Business Background [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r167", "r328", "r329", "r330", "r331", "r337", "r338", "r339", "r340", "r346", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r378", "r379", "r380", "r383", "r652", "r654", "r840", "r843", "r844" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Voting securities, percentage", "label": "Business Combination, Voting Equity Interest Acquired, Percentage", "documentation": "Percentage of voting equity interest acquired in business combination." } } }, "auth_ref": [ "r330", "r652", "r653" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business acquisition price (in Dollars per share)", "label": "Business Combination, Price Per Share", "documentation": "Per share price of saleable stock paid or offered to be paid by acquirer in business combination." } } }, "auth_ref": [ "r655", "r841", "r842", "r845", "r846" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash at bank", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r37", "r69", "r71", "r616", "r863" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r70" ] }, "kvac_CashAndInvestmentHeldInTrustAccountPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "CashAndInvestmentHeldInTrustAccountPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and investment held in trust account", "label": "Cash And Investment Held In Trust Account Policy Text Block", "documentation": "Disclosure of accounting policy for cash and investment held in trust account." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodEndLabel": "CASH AT BANK, END OF PERIOD", "periodStartLabel": "CASH AT BANK, BEGINNING OF PERIOD", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r12", "r69", "r71" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CHANGE IN CASH", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation", "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r12" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r69", "r71", "r772", "r870" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing activities:", "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "kvac_CashWithdrawnFromTrustAccountInConnectionToRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "CashWithdrawnFromTrustAccountInConnectionToRedemption", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash withdrawn from Trust Account in connection to redemption", "label": "Cash Withdrawn From Trust Account In Connection To Redemption", "documentation": "Proceeds from withdrawn from Trust Account in connection to redemption." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r723" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Financial Officer", "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r793" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r720" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r718" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CityAreaCode", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfStockDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Initial Public Offering [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfStockDomain", "presentation": [ "http://kvac.com/20260331/role/Cover", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r20", "r33", "r34", "r45", "r46", "r47", "r48", "r49", "r50", "r74", "r76", "r103", "r104", "r107", "r109", "r114", "r115", "r156", "r186", "r188", "r189", "r190", "r193", "r194", "r200", "r201", "r203", "r204", "r206", "r209", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r225", "r228", "r229", "r230", "r231", "r232", "r234", "r235", "r238", "r239", "r240", "r448", "r481", "r482", "r489", "r490", "r491", "r500", "r529", "r530", "r531", "r532", "r537", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r558", "r578", "r600", "r608", "r609", "r610", "r611", "r612", "r763", "r783", "r784", "r789", "r811", "r813" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfStockLineItems", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders\u2019 Deficit [Line Items]", "label": "Initial Public Offering [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r33", "r34", "r45", "r49", "r50", "r114", "r203", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r225", "r228", "r229", "r231", "r232", "r234", "r235", "r238", "r240", "r394", "r481", "r482", "r490", "r491", "r529", "r530", "r531", "r532", "r763", "r781", "r783", "r811" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r807" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [ "r807" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in Dollars per share)", "netLabel": "Exercise price", "verboseLabel": "Exercise price per share (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r74", "r77", "r229" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r807" ] }, "kvac_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum threshold written notice period for redemption of public warrants", "label": "Class Of Warrant Or Right Minimum Threshold Written Notice Period For Redemption Of Warrants", "documentation": "Represent the number of threshold days for written notice period for redemption of warrants." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Purchase of each warrant", "terseLabel": "Purchase of each warrant (in Shares)", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [ "r229" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase aggregate shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r807" ] }, "kvac_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of threshold consecutive trading days for redemption of warrants", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days", "documentation": "Represent the number of specified consecutive trading days for stock price trigger considered for redemption of warrants." } } }, "auth_ref": [] }, "kvac_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of threshold trading days for redemption of warrants", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days", "documentation": "Represent the number of specified trading days for stock price trigger considered for redemption of warrants." } } }, "auth_ref": [] }, "kvac_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price of warrants or rights", "label": "Class Of Warrant Or Right Redemption Price Of Warrants Or Rights", "documentation": "Class of warrant or right, redemption price of warrants or rights." } } }, "auth_ref": [] }, "kvac_ClosingNetValue": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "ClosingNetValue", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Closing net value", "label": "Closing Net Value", "documentation": "Closing net value." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r724" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r724" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 7)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r44", "r481", "r482", "r488", "r504", "r557" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r184", "r185", "r614", "r796", "r797", "r798" ] }, "kvac_CommitmentsandContingenciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "CommitmentsandContingenciesDetailsTable", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "verboseLabel": "Common Stock [Member]", "terseLabel": "Ordinary shares", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r50", "r235", "r481", "r482", "r491", "r665", "r666", "r667", "r669", "r670", "r671", "r672", "r786", "r787", "r788", "r850", "r872", "r874" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, par value (in Dollars per share)", "verboseLabel": "Ordinary shares, par value", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r778", "r809", "r865", "r866", "r869" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, shares authorized (in Shares)", "verboseLabel": "Ordinary shares, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r50", "r235", "r481", "r482", "r491", "r558" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesIssued", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, shares issued (in Shares)", "verboseLabel": "Ordinary share issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r50", "r235", "r481", "r482", "r491" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, shares outstanding (in Shares)", "verboseLabel": "Ordinary share outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r50", "r235", "r481", "r482", "r491", "r558", "r576", "r806", "r874", "r875" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of December 31, 2025 and 2024 (excluding 4,822,346 and 14,950,000 shares subject to possible redemption, respectively)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r50", "r201", "r208", "r235", "r481", "r482", "r491", "r505", "r662" ] }, "us-gaap_CommonStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockVotingRights", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, voting rights", "label": "Common Stock, Voting Rights", "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r643" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r729" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r728" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r730" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r727" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration of credit risk", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument." } } }, "auth_ref": [ "r446", "r447" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r5", "r622" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails", "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred underwriting commissions", "terseLabel": "Deferred underwriting compensation", "netLabel": "Deferred underwriting expenses", "label": "Deferred Compensation Liability, Classified, Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)." } } }, "auth_ref": [] }, "us-gaap_DeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredOfferingCosts", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other offering costs", "label": "Deferred Offering Costs", "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period." } } }, "auth_ref": [ "r795" ] }, "us-gaap_DepositAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DepositAssets", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deposit amount", "label": "Deposit Assets, Total", "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement." } } }, "auth_ref": [ "r771", "r773" ] }, "kvac_DepositingAmountToTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "DepositingAmountToTrustAccount", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depositing amount to trust account", "label": "Depositing Amount To Trust Account", "documentation": "Depositing amount to trust account." } } }, "auth_ref": [] }, "us-gaap_Deposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Deposits", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deposit", "label": "Deposits", "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others." } } }, "auth_ref": [ "r481", "r482", "r484", "r501" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentInformationLineItems", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentInformationTable", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentPeriodEndDate", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentQuarterlyReport", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r679" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentTransitionReport", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r711" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentType", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r722" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareBasic", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net income per share, ordinary shares subject to possible redemption (in Dollars per share)", "verboseLabel": "Basic net income (loss) per share (in Dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r26", "r63", "r85", "r88", "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r100", "r103", "r107", "r108", "r109", "r111", "r181", "r199", "r257", "r302", "r326", "r388", "r425", "r426", "r496", "r512", "r623" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareDiluted", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted net income per share, ordinary shares subject to possible redemption (in Dollars per share)", "verboseLabel": "Diluted net income (loss) per share (in Dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r26", "r63", "r85", "r88", "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r103", "r107", "r108", "r109", "r111", "r181", "r199", "r257", "r302", "r326", "r388", "r425", "r426", "r496", "r512", "r623" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Net income (loss) per share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r110" ] }, "kvac_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Emerging growth company", "label": "Emerging Growth Company Policy Text Block", "documentation": "The entire disclosure for emerging growth company." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressAddressLine1", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressCityOrTown", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCentralIndexKey", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r677" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityDomain", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r677" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityExTransitionPeriod", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r762" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityFileNumber", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityFilerCategory", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r677" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r761" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityRegistrantName", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r677" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityShellCompany", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r677" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntitySmallBusiness", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r677" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r677" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r716" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r757" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r757" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r757" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Deficit [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityComponentDomain", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r25", "r26", "r33", "r49", "r50", "r60", "r61", "r62", "r80", "r81", "r82", "r86", "r94", "r96", "r98", "r113", "r157", "r160", "r180", "r181", "r183", "r198", "r228", "r233", "r234", "r235", "r238", "r240", "r243", "r255", "r256", "r260", "r261", "r302", "r315", "r316", "r322", "r323", "r324", "r327", "r387", "r388", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r406", "r410", "r411", "r412", "r413", "r424", "r449", "r450", "r451", "r452", "r453", "r454", "r456", "r462", "r479", "r481", "r482", "r490", "r491", "r500", "r511", "r515", "r516", "r517", "r537", "r600", "r813" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r726" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r684", "r694", "r704", "r736" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r681", "r691", "r701", "r733" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r732" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value Hierarchy of the Valuation Techniques", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r851", "r852" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Hierarchy of the Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r442", "r658" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r195", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r427", "r428", "r430", "r431", "r432", "r433", "r440", "r441", "r443", "r445", "r475", "r476", "r477", "r478", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r657", "r659", "r660", "r661" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r429", "r430", "r431", "r433", "r657", "r854", "r856" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quoted Prices In Active Markets (Level 1) [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r195", "r262", "r267", "r269", "r430", "r441", "r445", "r475", "r644", "r645", "r646", "r647", "r648", "r657", "r660", "r661" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r195", "r262", "r267", "r269", "r271", "r430", "r431", "r441", "r445", "r476", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r657", "r660", "r661" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Other Unobservable Inputs (Level 3) [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r195", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r430", "r431", "r432", "r433", "r441", "r445", "r477", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r657", "r659", "r660", "r661" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r429", "r430", "r431", "r433", "r657", "r854", "r856" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r195", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r427", "r428", "r430", "r431", "r432", "r433", "r440", "r441", "r443", "r445", "r475", "r476", "r477", "r478", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r657", "r659", "r660", "r661" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recurring Basis [Member]", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r657", "r851", "r852", "r853", "r854", "r855", "r856" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of financial instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r857" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r688", "r698", "r708", "r740" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r688", "r698", "r708", "r740" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r688", "r698", "r708", "r740" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r688", "r698", "r708", "r740" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r688", "r698", "r708", "r740" ] }, "kvac_FounderShares1Member": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "FounderShares1Member", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Founder Shares [Member]", "label": "Founder Shares1 Member" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r721" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IPOMember", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Public Offering [Member]", "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r59", "r307", "r308", "r311", "r312", "r313", "r314", "r528" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepayment", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r3" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r688", "r698", "r708", "r732", "r740", "r744", "r752" ] }, "kvac_InitialPublicOfferingDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "InitialPublicOfferingDetailsTable", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "label": "Initial Public Offering (Details) [Table]" } } }, "auth_ref": [] }, "kvac_InitialPublicOfferingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "InitialPublicOfferingTextBlock", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOffering" ], "lang": { "en-us": { "role": { "terseLabel": "INITIAL PUBLIC OFFERING", "label": "Initial Public Offering Text Block", "documentation": "The entire disclosure on information about initial public offering." } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r750" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r680", "r756" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r680", "r756" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r680", "r756" ] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InvestmentIncomeDividend", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividend income earned in cash and investments held in trust account", "verboseLabel": "Dividend income earned in investments held in Trust Account", "label": "Investment Income, Dividend", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_InvestmentIncomeInterestAndDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InvestmentIncomeInterestAndDividend", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend income earned in investments held in Trust Account", "label": "Investment Income, Interest and Dividend", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r7", "r8" ] }, "kvac_KVACCaymanLimitedAcquirerMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "KVACCaymanLimitedAcquirerMember", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "KVAC (Cayman) Limited (\u201cAcquirer\u201d) [Member]", "label": "KVACCayman Limited Acquirer Member" } } }, "auth_ref": [] }, "kvac_KVACMSCaymanLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "KVACMSCaymanLimitedMember", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "KVAC MS (Cayman) Limited [Member]", "label": "KVACMSCayman Limited Member" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "LegalEntityAxis", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r30", "r31", "r74", "r75", "r76", "r156", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r239", "r391", "r392", "r393", "r448", "r556", "r627", "r642", "r675", "r779", "r799", "r861", "r862" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r54", "r481", "r482", "r493", "r508", "r662", "r663", "r664", "r781", "r785", "r794", "r858" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r31", "r32", "r41", "r74", "r75", "r76", "r156", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r239", "r391", "r392", "r393", "r448", "r662", "r799", "r861", "r862" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "LocalPhoneNumber", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "kvac_MaturityInvestedTerm": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "MaturityInvestedTerm", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity period", "label": "Maturity Invested Term", "documentation": "The maturity invested term." } } }, "auth_ref": [] }, "kvac_MaximumNetInterestToPayDissolutionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "MaximumNetInterestToPayDissolutionExpenses", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dissolution expenses", "label": "Maximum Net Interest To Pay Dissolution Expenses", "documentation": "\"Represents the maximum net interest to pay dissolution expenses.\n \n\"" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r724" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r724" ] }, "kvac_MinimumNetTangibleAssetsUponConsummationOfBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "MinimumNetTangibleAssetsUponConsummationOfBusinessCombination", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net tangible assets", "label": "Minimum Net Tangible Assets Upon Consummation Of Business Combination", "documentation": "Amount of net tangible assets upon consummation of business." } } }, "auth_ref": [] }, "kvac_MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary per share equals or exceeds", "label": "Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders", "documentation": "Minimum threshold price of common stock specified to send notice of redemption to the warrant holders." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r743" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r751" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r725" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NatureOfOperations", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackground" ], "lang": { "en-us": { "role": { "terseLabel": "ORGANIZATION AND BUSINESS BACKGROUND", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r17", "r117", "r624", "r625" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r68" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r68" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r12", "r13", "r14" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "NET INCOME", "verboseLabel": "Net income", "definitionGuidance": "Net income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r6", "r14", "r16", "r26", "r30", "r31", "r57", "r58", "r62", "r74", "r75", "r76", "r79", "r85", "r90", "r91", "r92", "r93", "r94", "r97", "r98", "r105", "r156", "r181", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r199", "r202", "r205", "r210", "r239", "r257", "r302", "r326", "r388", "r426", "r448", "r510", "r577", "r598", "r599", "r619", "r620", "r621", "r673", "r799" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total allocation to redeemable and non-redeemable ordinary shares", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r26", "r64", "r90", "r91", "r92", "r93", "r100", "r101", "r106", "r109", "r202", "r205", "r210", "r388" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerators:", "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r21", "r22", "r23", "r24", "r25", "r26", "r65", "r66", "r67", "r83", "r84", "r85", "r86", "r87", "r88", "r89", "r92", "r99", "r111", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r196", "r197", "r198", "r199", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r300", "r301", "r302", "r303", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r347", "r348", "r349", "r384", "r385", "r386", "r387", "r388", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r444", "r457", "r458", "r459", "r460", "r461", "r462", "r479", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r526" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent issued accounting standards", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [ "r99" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r724" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r688", "r698", "r708", "r732", "r740" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r715" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r714" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r732" ] }, "kvac_NonRedeemableOrdinaryShareMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "NonRedeemableOrdinaryShareMember", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non- Redeemable Ordinary Share [Member]", "label": "Non Redeemable Ordinary Share Member" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r751" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r751" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r9", "r766", "r767", "r794" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NumberOfOperatingSegments", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segment", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r634", "r792" ] }, "kvac_NumberOfSharesIssuedPerUnit": { "xbrltype": "sharesItemType", "nsuri": "http://kvac.com/20260331", "localname": "NumberOfSharesIssuedPerUnit", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares issued per unit", "label": "Number Of Shares Issued Per Unit", "documentation": "Number of shares issued per unit." } } }, "auth_ref": [] }, "kvac_NumberOfTradingDaysAfterCompletionOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "NumberOfTradingDaysAfterCompletionOfBusinessCombination", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days after completion of business combination", "label": "Number Of Trading Days After Completion Of Business Combination", "documentation": "Represent the number of number of trading days after completion of business combination." } } }, "auth_ref": [] }, "kvac_NumberOfTradingDaysStartingPriorDateOfConsummationOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "NumberOfTradingDaysStartingPriorDateOfConsummationOfBusinessCombination", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days starting prior date of consummation of business combination", "label": "Number Of Trading Days Starting Prior Date Of Consummation Of Business Combination", "documentation": "Represent the number of trading days starting prior date of consummation of business combination." } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Formation and operating costs", "label": "Operating Costs and Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingExpenses", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Total expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [ "r621", "r766", "r767", "r794" ] }, "kvac_OrdinaryShares00001ParValueMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "OrdinaryShares00001ParValueMember", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares, $0.0001 par value", "label": "Ordinary Shares00001 Par Value Member" } } }, "auth_ref": [] }, "kvac_OrdinarySharesNotSubjectToPossibleRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "OrdinarySharesNotSubjectToPossibleRedemptionMember", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares Not Subject to Possible Redemption", "label": "Ordinary Shares Not Subject To Possible Redemption Member" } } }, "auth_ref": [] }, "kvac_OrdinarySharesSubjectToPossibleRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "OrdinarySharesSubjectToPossibleRedemptionMember", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares Subject to Possible Redemption", "label": "Ordinary Shares Subject To Possible Redemption Member" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization and Business Background [Abstract]" } } }, "auth_ref": [] }, "kvac_OrganizationandBusinessBackgroundDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "OrganizationandBusinessBackgroundDetailsTable", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Business Background (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherIncomeAbstract", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other income:", "label": "Component of Operating Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due to a related party", "verboseLabel": "Temporary advance", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35", "r39", "r40", "r662" ] }, "us-gaap_OtherNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherNotesPayableCurrent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Note payable", "terseLabel": "Extension promissory note payable", "label": "Other Notes Payable, Current", "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r774" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r724" ] }, "us-gaap_OtherUnderwritingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherUnderwritingExpense", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriting commissions", "label": "Other Underwriting Expense", "documentation": "Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts." } } }, "auth_ref": [ "r871" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r686", "r696", "r706", "r738" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r689", "r699", "r709", "r741" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r689", "r699", "r709", "r741" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OverAllotmentOptionMember", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Over-Allotment Option [Member]", "label": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "OwnershipAxis", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [ "r238", "r240" ] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "OwnershipDomain", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "auth_ref": [ "r238", "r240" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r713" ] }, "kvac_PaymentOfAggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "PaymentOfAggregateAmount", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "label": "Payment of Aggregate Amount", "documentation": "Represent the amount of aggregate amount." } } }, "auth_ref": [] }, "us-gaap_PaymentsForFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForFees", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fees incurred", "label": "Payments for Other Fees", "documentation": "Amount of cash outflow for fees classified as other." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment for month rent", "label": "Payments for Rent", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Redemption of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Extension payments deposited in Trust Account", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r10" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r723" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r723" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r715" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r732" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r725" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r714" ] }, "kvac_PercentageObligationToRedeemPublicShares": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageObligationToRedeemPublicShares", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding public shares, percentage", "label": "Percentage Obligation To Redeem Public Shares", "documentation": "Percentage of shares which the reporting entity is obligated to redeem." } } }, "auth_ref": [] }, "kvac_PercentageOfAggregateFairMarketValueOfAsset": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfAggregateFairMarketValueOfAsset", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of aggregate fair market value", "label": "Percentage Of Aggregate Fair Market Value Of Asset", "documentation": "Represents the minimum percentage of aggregate fair market value of assets." } } }, "auth_ref": [] }, "kvac_PercentageOfExercisePriceWarrants": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfExercisePriceWarrants", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of exercise price warrants", "label": "Percentage Of Exercise Price Warrants", "documentation": "Percentage of exercise price warrants." } } }, "auth_ref": [] }, "kvac_PercentageOfIssuedAndOutstandingOrdinaryShares": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfIssuedAndOutstandingOrdinaryShares", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of issued and outstanding ordinary shares", "label": "Percentage Of Issued And Outstanding Ordinary Shares", "documentation": "Percentage of issued and outstanding ordinary shares." } } }, "auth_ref": [] }, "kvac_PercentageOfIssuedAndOutstandingShares": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfIssuedAndOutstandingShares", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued and outstanding shares after the initial public offering", "label": "Percentage Of Issued And Outstanding Shares", "documentation": "Percentage of issued and outstanding shares." } } }, "auth_ref": [] }, "kvac_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of issued and outstanding shares", "label": "Percentage Of Issued And Outstanding Shares After Initial Public Offering Collectively Held By Initial Stockholders", "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering." } } }, "auth_ref": [] }, "kvac_PercentageOfMarketValue": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "PercentageOfMarketValue", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of market value", "label": "Percentage Of Market Value", "documentation": "Percentage of market value." } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r716" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r760" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r715" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayment", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r55", "r165", "r166", "r618" ] }, "kvac_PricePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "PricePerUnit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price per unit (in Dollars per share)", "verboseLabel": "Price per unit (in Dollars per share)", "label": "Price Per Unit", "documentation": "Price per unit." } } }, "auth_ref": [] }, "kvac_PriceThresholdFairMarketValueOfExerciseOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "PriceThresholdFairMarketValueOfExerciseOfWarrants", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price threshold fair market value of exercise of warrants", "label": "Price Threshold Fair Market Value Of Exercise Of Warrants", "documentation": "Price threshold fair market value of exercise of warrants." } } }, "auth_ref": [] }, "kvac_PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective issue price per share", "label": "Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price", "documentation": "Price threshold of newly issued stock to cause adjustment of exercise warrant price." } } }, "auth_ref": [] }, "kvac_PrivatePlacementDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "PrivatePlacementDetailsTable", "presentation": [ "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PrivatePlacementMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement [Member]", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "kvac_PrivatePlacementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "PrivatePlacementsTextBlock", "presentation": [ "http://kvac.com/20260331/role/PrivatePlacement" ], "lang": { "en-us": { "role": { "terseLabel": "PRIVATE PLACEMENT", "label": "Private Placements Text Block", "documentation": "The entire disclosure of private placement." } } }, "auth_ref": [] }, "kvac_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "PrivateWarrantsMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Warrants [Member]", "label": "Private Warrants Member" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds", "label": "Proceeds from Issuance Initial Public Offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds from private", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceed from extension promissory note payable - related party", "label": "Proceeds from Notes Payable", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "calculation": { "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Advance from a related party", "label": "Proceeds from Related Party Debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromUnsecuredNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromUnsecuredNotesPayable", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued an unsecured promissory note", "verboseLabel": "Unsecured promissory note", "label": "Proceeds from Unsecured Notes Payable", "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral)." } } }, "auth_ref": [ "r4" ] }, "kvac_ProceedsToBeUsedForBusinessCombinationAsAPercentageOfTotalCapitalRaising": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "ProceedsToBeUsedForBusinessCombinationAsAPercentageOfTotalCapitalRaising", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate gross proceeds percentage", "label": "Proceeds To Be Used For Business Combination As APercentage Of Total Capital Raising", "documentation": "Proceeds to be used for business combination as a percentage of total capital raising." } } }, "auth_ref": [] }, "kvac_PublicShareMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "PublicShareMember", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Share [Member]", "label": "Public Share Member" } } }, "auth_ref": [] }, "kvac_PublicWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "PublicWarrantMember", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Warrant [Member]", "label": "Public Warrant Member", "documentation": "Public warrant [Member]." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r713" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r713" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r681", "r691", "r701", "r733" ] }, "kvac_RedeemableOrdinaryShareMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "RedeemableOrdinaryShareMember", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Ordinary Share [Member]", "label": "Redeemable Ordinary Share Member" } } }, "auth_ref": [] }, "kvac_RedemptionOfPercentageOfCommonStockIncludedInUnitsSoldInOffering": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "RedemptionOfPercentageOfCommonStockIncludedInUnitsSoldInOffering", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption, percentage", "label": "Redemption Of Percentage Of Common Stock Included In Units Sold In Offering", "documentation": "\"Percentage of the total shares of Class A common stock sold in the Initial Public Offering that a Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a \"\"group\"\" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the \"\"Exchange Act\"\")), above which will be restricted from redeeming, without the prior consent of the Company.\n \n\"" } } }, "auth_ref": [] }, "kvac_RedemptionSharePercentage": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "RedemptionSharePercentage", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption share percentage", "label": "Redemption Share Percentage", "documentation": "Redemption share percentage." } } }, "auth_ref": [] }, "kvac_RedemptionTriggerPrice": { "xbrltype": "perShareItemType", "nsuri": "http://kvac.com/20260331", "localname": "RedemptionTriggerPrice", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption trigger price", "label": "Redemption Trigger Price", "documentation": "Redemption trigger price per share." } } }, "auth_ref": [] }, "kvac_RelatedPartiesPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "RelatedPartiesPolicyPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Related parties", "label": "Related Parties Policy Policy Text Block", "documentation": "Disclosure of accounting policy for related parties." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyDomain", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r35", "r36", "r39", "r42", "r43", "r74", "r78", "r79", "r155", "r268", "r272", "r466", "r467", "r481", "r482", "r485", "r486", "r487", "r494", "r503", "r509", "r551", "r552", "r553", "r554", "r555", "r575", "r607", "r617", "r873", "r876" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyMember", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Related Party [Member]", "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r35", "r36", "r39", "r42", "r43", "r74", "r78", "r79", "r466", "r467", "r468", "r469", "r481", "r482", "r487", "r503", "r509", "r551", "r552", "r553", "r554", "r555", "r575", "r607" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r74", "r78", "r79", "r466", "r467", "r860" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [ "r74", "r78", "r79", "r860" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r74", "r78", "r79", "r155", "r466", "r467", "r469", "r481", "r482", "r485", "r486", "r487", "r494", "r581", "r582", "r585", "r876" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r35", "r36", "r39", "r42", "r43", "r74", "r78", "r79", "r155", "r268", "r272", "r466", "r467", "r481", "r482", "r485", "r486", "r487", "r494", "r503", "r509", "r551", "r552", "r553", "r554", "r555", "r575", "r607", "r617", "r860", "r873", "r876" ] }, "kvac_RelatedPartyTransactionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "RelatedPartyTransactionsDetailsTable", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTY TRANSACTIONS", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r463", "r464", "r465", "r467", "r470", "r481", "r482", "r495", "r534", "r535", "r536", "r583", "r584", "r585", "r604", "r606" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r682", "r692", "r702", "r734" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r683", "r693", "r703", "r735" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r690", "r700", "r710", "r742" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r51", "r52", "r236", "r481", "r482", "r492", "r507", "r519", "r524", "r533", "r559", "r662" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsMember", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r25", "r26", "r80", "r81", "r82", "r86", "r94", "r96", "r98", "r157", "r160", "r180", "r181", "r183", "r198", "r233", "r243", "r255", "r256", "r260", "r261", "r302", "r315", "r316", "r322", "r323", "r324", "r327", "r387", "r388", "r397", "r398", "r399", "r400", "r402", "r403", "r406", "r424", "r456", "r479", "r500", "r515", "r517", "r537", "r810", "r812", "r874" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r751" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r751" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price per unit (in Dollars per share)", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScenarioForecastMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast [Member]", "label": "Forecast [Member]" } } }, "auth_ref": [ "r273" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r27", "r28", "r99", "r273", "r764" ] }, "kvac_ScheduleOfConsolidatedFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "ScheduleOfConsolidatedFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Consolidated Financial Statements Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r790" ] }, "kvac_ScheduleOfFairValueHierarchyOfTheValuationTechniquesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "ScheduleOfFairValueHierarchyOfTheValuationTechniquesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Hierarchy Of The Valuation Techniques Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total." } } }, "auth_ref": [ "r122", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r139", "r140", "r141", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r151" ] }, "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Consolidated Financial Statements", "label": "Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block]", "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary of LLC or LP [Table]", "documentation": "Disclosure of information about subsidiary of limited liability company (LLC) or limited partnership (LP)." } } }, "auth_ref": [] }, "kvac_ScheduleOfUnauditedCondensedConsolidatedStatementsOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "ScheduleOfUnauditedCondensedConsolidatedStatementsOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Unaudited Condensed Consolidated Statements Of Income And Comprehensive Income Abstract" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "Security12bTitle", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r676" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "SecurityExchangeName", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r678" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]", "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]", "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting." } } }, "auth_ref": [ "r125", "r632", "r639" ] }, "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of segment", "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description", "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource." } } }, "auth_ref": [ "r142", "r629", "r636" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://kvac.com/20260331/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "SEGMENT INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for segment reporting." } } }, "auth_ref": [ "r112", "r121", "r122", "r123", "r124", "r126", "r138", "r140", "r141", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r628", "r630", "r631", "r633", "r635", "r637", "r638" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r122", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r139", "r140", "r141", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r151" ] }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Member]", "label": "Business Combination, Series of Individually Immaterial Business Combinations [Member]", "documentation": "Series of individually immaterial business combinations." } } }, "auth_ref": [ "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r840", "r843", "r844" ] }, "kvac_ServiceFeesUnpaid": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "ServiceFeesUnpaid", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Services fee", "label": "Service Fees Unpaid", "documentation": "Represents the amount of service fees paid." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharePrice", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemed price per share", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "kvac_ShareholdersDeficitDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "ShareholdersDeficitDetailsTable", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Deficit (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price per share (in Dollars per share)", "verboseLabel": "Purchase price per share (in Dollars per share)", "label": "Shares Issued, Price Per Share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharesOutstanding", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [ "r806", "r810", "r812" ] }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares subject to possible redemption", "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security." } } }, "auth_ref": [ "r801" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r72", "r73" ] }, "kvac_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "SponsorMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor [Member]", "label": "Sponsor Member" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementClassOfStockAxis", "presentation": [ "http://kvac.com/20260331/role/Cover", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r20", "r33", "r34", "r45", "r46", "r47", "r48", "r49", "r50", "r74", "r76", "r103", "r104", "r107", "r109", "r114", "r115", "r156", "r186", "r188", "r189", "r190", "r193", "r194", "r200", "r201", "r203", "r204", "r206", "r209", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r225", "r228", "r229", "r230", "r231", "r232", "r234", "r235", "r238", "r239", "r240", "r448", "r481", "r482", "r489", "r490", "r491", "r500", "r529", "r530", "r531", "r532", "r537", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r558", "r578", "r600", "r608", "r609", "r610", "r611", "r612", "r763", "r783", "r784", "r789", "r811", "r813" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r25", "r26", "r33", "r49", "r50", "r60", "r61", "r62", "r80", "r81", "r82", "r86", "r94", "r96", "r98", "r113", "r157", "r160", "r180", "r181", "r183", "r198", "r228", "r233", "r234", "r235", "r238", "r240", "r243", "r255", "r256", "r260", "r261", "r302", "r315", "r316", "r322", "r323", "r324", "r327", "r387", "r388", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r406", "r410", "r411", "r412", "r413", "r424", "r449", "r450", "r451", "r452", "r453", "r454", "r456", "r462", "r479", "r481", "r482", "r490", "r491", "r500", "r511", "r515", "r516", "r517", "r537", "r600", "r813" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementLineItems", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r33", "r34", "r35", "r36", "r39", "r42", "r43", "r45", "r48", "r49", "r50", "r52", "r80", "r81", "r82", "r113", "r200", "r201", "r203", "r206", "r212", "r228", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r240", "r242", "r243", "r252", "r456", "r480", "r481", "r482", "r489", "r490", "r491", "r527", "r538", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r558", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r579", "r580", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r600", "r617", "r620", "r621", "r668", "r873" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "StatementScenarioAxis", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r27", "r28", "r99", "r273", "r764", "r765" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementTable", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r29", "r33", "r34", "r35", "r36", "r39", "r42", "r43", "r45", "r48", "r49", "r50", "r52", "r80", "r81", "r82", "r113", "r155", "r200", "r201", "r203", "r206", "r212", "r228", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r240", "r242", "r243", "r252", "r456", "r480", "r481", "r482", "r489", "r490", "r491", "r500", "r527", "r538", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r558", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r579", "r580", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r600", "r617", "r620", "r621", "r668", "r873" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r685", "r695", "r705", "r737" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares (in Shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r529", "r600", "r609", "r769", "r777", "r778", "r806", "r808", "r809", "r810", "r812", "r865", "r866", "r868", "r869" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares subject to forfeiture (in Shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r769", "r777", "r778", "r806", "r808", "r809", "r810", "r812", "r865", "r866", "r868", "r869" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r282", "r769", "r777", "r778", "r806", "r808", "r809", "r810", "r812", "r865", "r866", "r868", "r869" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate purchase price", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r537", "r600", "r609", "r674", "r769", "r777", "r778", "r806", "r808", "r809", "r810", "r812", "r865", "r866", "r868", "r869" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRedeemedOrCalledDuringPeriodShares", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemed shares (in Shares)", "label": "Stock Redeemed or Called During Period, Shares", "documentation": "Number of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r777", "r778", "r806", "r808", "r809" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRedeemedOrCalledDuringPeriodValue", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "label": "Stock Redeemed or Called During Period, Value", "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r769", "r777", "r778", "r806", "r808", "r809" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders\u2019 Deficit", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r15", "r560", "r576", "r601", "r602", "r662", "r675", "r779", "r781", "r784", "r785", "r794", "r858", "r874" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityAbstract", "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders\u2019 Deficit:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS\u2019 DEFICIT", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r33", "r49", "r50", "r53", "r211", "r214", "r216", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r234", "r235", "r238", "r240", "r241", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r394", "r414", "r415", "r474", "r603", "r605", "r613" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventLineItems", "presentation": [ "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r455", "r472" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventMember", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r455", "r472" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r455", "r472" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails", "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r455", "r472" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "kvac_SubsequentEventsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "SubsequentEventsDetailsTable", "presentation": [ "http://kvac.com/20260331/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://kvac.com/20260331/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r471", "r473" ] }, "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Background", "label": "Subsidiary of Limited Liability Company or Limited Partnership, Business Purpose", "documentation": "Description of business purpose of the subsidiary of the limited liability company or limited partnership, for example, its day-to-day operating functions and whether it acts as a holding or operating company." } } }, "auth_ref": [] }, "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Consolidated Financial Statements [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership", "label": "Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest", "documentation": "The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails", "http://kvac.com/20260331/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "kvac_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "kvac_SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetailsTable", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueHierarchyoftheValuationTechniquesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Fair Value Hierarchy of the Valuation Techniques (Details) [Table]" } } }, "auth_ref": [] }, "kvac_SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetailsLineItems", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income", "label": "Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) [Line Items]" } } }, "auth_ref": [] }, "kvac_SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://kvac.com/20260331", "localname": "SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetailsTable", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Details) [Table]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r731" ] }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquityAccretionToRedemptionValue", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofChangesinShareholdersDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Accretion of carrying value to redemption value", "label": "Temporary Equity, Accretion to Redemption Value", "documentation": "Value of accretion of temporary equity to its redemption value during the period." } } }, "auth_ref": [ "r770", "r776", "r802", "r803", "r804", "r805", "r865", "r866", "r867" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://kvac.com/20260331/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, 4,822,346 and 14,950,000 shares subject to possible redemption issued and outstanding as of December 31, 2025 and 2024, respectively", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r34", "r45", "r48", "r186", "r188", "r189", "r190", "r193", "r194", "r200", "r201", "r203", "r207", "r239", "r304", "r305", "r481", "r482", "r489", "r506" ] }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquityRedemptionPricePerShare", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price (in Dollars per share)", "label": "Temporary Equity, Redemption Price Per Share", "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r770", "r775", "r865", "r866", "r867" ] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Ordinary shares subject to possible redemption issued", "terseLabel": "Shares subject to possible redemption, shares issued (in Shares)", "label": "Temporary Equity, Shares Issued", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r34", "r45", "r203", "r481", "r482", "r489" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://kvac.com/20260331/role/ConsolidatedBalanceSheetsParentheticals", "http://kvac.com/20260331/role/ShareholdersDeficitDetails", "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Ordinary shares subject to possible redemption", "terseLabel": "Shares subject to possible redemption, shares outstanding (in Shares)", "netLabel": "Ordinary shares subject to possible redemption outstanding", "label": "Temporary Equity, Shares Outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r34", "r45", "r203", "r481", "r482", "r489" ] }, "kvac_ThresholdNumberOfBusinessDaysToRedeemPublicSharesFromCombinationPeriod": { "xbrltype": "percentItemType", "nsuri": "http://kvac.com/20260331", "localname": "ThresholdNumberOfBusinessDaysToRedeemPublicSharesFromCombinationPeriod", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding shares, percentage", "label": "Threshold Number Of Business Days To Redeem Public Shares From Combination Period", "documentation": "\"Represents the threshold number of business days to redeem Public Shares from Combination Period if the Company has not completed an Initial Business Combination." } } }, "auth_ref": [] }, "kvac_ThresholdPeriodForEffectiveWithInStatementAfterBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "ThresholdPeriodForEffectiveWithInStatementAfterBusinessCombination", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold period for effective within statement after business combination", "label": "Threshold Period For Effective With In Statement After Business Combination", "documentation": "Represent the number of threshold days for effective with in statement after business combination." } } }, "auth_ref": [] }, "kvac_ThresholdPeriodForNotEffectiveWithinStatementAfterBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://kvac.com/20260331", "localname": "ThresholdPeriodForNotEffectiveWithinStatementAfterBusinessCombination", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold period for not effective within statement after business combination", "label": "Threshold Period For Not Effective Within Statement After Business Combination", "documentation": "Represent the number of threshold days for not effective within statement after business combination." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualAxis", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r793", "r859" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://kvac.com/20260331/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Domain]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r723" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r730" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r750" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r752" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "TradingSymbol", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "kvac_TransactionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "TransactionCost", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction cost", "label": "Transaction Cost", "documentation": "Represents the amount of transaction cost." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r753" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r754" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r754" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r752" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r752" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r755" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r753" ] }, "kvac_TrustAccountMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "TrustAccountMember", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "label": "Trust Account [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TypeOfArrangementAxis", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r389" ] }, "kvac_UnderwriterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "UnderwriterAgreementMember", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriter Agreement [Member]", "label": "Underwriter Agreement Member" } } }, "auth_ref": [] }, "us-gaap_UnderwritingExpenseRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnderwritingExpenseRatio", "presentation": [ "http://kvac.com/20260331/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriting discount rate", "label": "Underwriting Expense Ratio", "documentation": "Ratio of non-life acquisition expenses and certain non-life general and administrative expenses, to non-life net premiums earned." } } }, "auth_ref": [ "r791" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r749" ] }, "kvac_UnitsEachConsistingOfOneOrdinaryShareAndOneRedeemableWarrantToAcquireOneOrdinaryShareMember": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "UnitsEachConsistingOfOneOrdinaryShareAndOneRedeemableWarrantToAcquireOneOrdinaryShareMember", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share", "label": "Units Each Consisting Of One Ordinary Share And One Redeemable Warrant To Acquire One Ordinary Share Member" } } }, "auth_ref": [] }, "kvac_UnitsIssuedDuringPeriodSharesNewIssued": { "xbrltype": "sharesItemType", "nsuri": "http://kvac.com/20260331", "localname": "UnitsIssuedDuringPeriodSharesNewIssued", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of units (in Shares)", "label": "Units Issued During Period Shares New Issued", "documentation": "The share amount of new shares issued." } } }, "auth_ref": [] }, "kvac_UnitsIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://kvac.com/20260331", "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://kvac.com/20260331/role/InitialPublicOfferingDetails", "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails", "http://kvac.com/20260331/role/PrivatePlacementDetails" ], "lang": { "en-us": { "role": { "netLabel": "Number of units", "verboseLabel": "Sale of public units", "terseLabel": "Company consummated sale (in Shares)", "label": "Units Issued During Period Shares New Issues", "documentation": "Number of new units issued during the period." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "label": "Unrecognized Tax Benefits, Beginning Balance", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r306", "r310", "r651" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued for interest and penalties", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r309", "r651" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UseOfEstimates", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r18", "r19", "r116", "r118", "r119", "r120", "r497", "r499", "r626" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r719" ] }, "kvac_WarrantAccountingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://kvac.com/20260331", "localname": "WarrantAccountingPolicyTextBlock", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant accounting", "label": "Warrant Accounting Policy Text Block", "documentation": "The disclosure of accounting warrant accounting." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WarrantMember", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant [Member]", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r665", "r666", "r669", "r670", "r671", "r672" ] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Private Placement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://kvac.com/20260331/role/ShareholdersDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants term", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r853", "r854", "r855" ] }, "kvac_WarrantsEachExercisableForOneOrdinaryShareAtAnExercisePriceOf1150Member": { "xbrltype": "domainItemType", "nsuri": "http://kvac.com/20260331", "localname": "WarrantsEachExercisableForOneOrdinaryShareAtAnExercisePriceOf1150Member", "presentation": [ "http://kvac.com/20260331/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants, each exercisable for one ordinary share at an exercise price of $11.50", "label": "Warrants Each Exercisable For One Ordinary Share At An Exercise Price Of1150 Member" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r102", "r109" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails", "http://kvac.com/20260331/role/UnauditedCondensedConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares)", "verboseLabel": "Weighted-average shares outstanding (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r100", "r109" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "presentation": [ "http://kvac.com/20260331/role/SummaryofSignificantAccountingPoliciesScheduleofUnauditedCondensedConsolidatedStatementsofIncomeandComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominators:", "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]" } } }, "auth_ref": [] }, "kvac_WorkingCapitalDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://kvac.com/20260331", "localname": "WorkingCapitalDeficit", "crdr": "debit", "presentation": [ "http://kvac.com/20260331/role/OrganizationandBusinessBackgroundDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital deficit", "label": "Working Capital Deficit", "documentation": "The amount represents working capital deficit." } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r717" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 1.B.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-6" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-6" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-7" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-7" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480125/505-10-S35-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-4" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-8" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 5.Q.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-7" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-3" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 1.D.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479921/505-20-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479772/718-30-S55-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479279/805-10-65-5" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479279/805-10-65-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479279/805-10-65-5" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-7" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-7" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-7" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "45", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480865/815-45-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 1.B.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480148/855-10-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-5" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(e)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(e)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "805", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r620": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r621": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r622": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r623": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r624": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4" }, "r626": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r628": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r629": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r630": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r631": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r632": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r633": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r634": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r635": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r636": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r637": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r638": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r639": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r641": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r642": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r643": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r649": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r650": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479299/805-40-55-10" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r676": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r677": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r680": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r681": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r682": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r683": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r684": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r685": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r686": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r687": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r688": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r689": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r690": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r691": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r692": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r693": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r694": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r695": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r696": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r698": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r699": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r700": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r701": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r702": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r703": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r704": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r705": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r706": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r707": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r708": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r709": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r763": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r764": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r765": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-7" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/480/tableOfContent" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-2" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480031/860-30-S50-1" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "810", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477383/970-810-45-1" } } } ZIP 52 0001213900-26-053981-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-26-053981-xbrl.zip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end XML 53 ea0289416-10q_keen_htm.xml IDEA: XBRL DOCUMENT 0001889983 2026-01-01 2026-03-31 0001889983 us-gaap:SubsequentEventMember 2026-04-27 2026-04-27 0001889983 kvac:UnderwriterAgreementMember 2026-03-31 0001889983 kvac:UnderwriterAgreementMember 2026-01-01 2026-03-31 0001889983 2026-03-31 0001889983 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001889983 kvac:PublicWarrantMember 2026-01-01 2026-03-31 0001889983 us-gaap:WarrantMember 2026-03-31 0001889983 kvac:FounderShares1Member 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2025-12-31 0001889983 us-gaap:CommonStockMember 2026-03-31 0001889983 2025-12-31 0001889983 us-gaap:RelatedPartyMember 2025-12-31 0001889983 us-gaap:RelatedPartyMember 2026-03-31 0001889983 kvac:SponsorMember us-gaap:SubsequentEventMember 2026-04-27 0001889983 kvac:SponsorMember 2026-01-26 0001889983 kvac:SponsorMember 2025-12-19 0001889983 kvac:SponsorMember 2025-11-18 0001889983 kvac:SponsorMember 2025-10-21 0001889983 kvac:SponsorMember 2025-09-19 0001889983 kvac:SponsorMember 2025-08-18 0001889983 kvac:SponsorMember 2025-07-23 0001889983 kvac:SponsorMember 2025-06-23 2025-06-23 0001889983 kvac:SponsorMember 2025-05-20 2025-05-20 0001889983 kvac:SponsorMember 2025-04-25 2025-04-25 0001889983 kvac:SponsorMember 2025-03-24 2025-03-24 0001889983 kvac:SponsorMember 2025-02-24 2025-02-24 0001889983 kvac:SponsorMember 2025-01-22 2025-01-22 0001889983 kvac:SponsorMember 2024-12-23 2024-12-23 0001889983 kvac:SponsorMember 2024-11-20 2024-11-20 0001889983 kvac:SponsorMember 2024-10-28 2024-10-28 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-03-31 0001889983 2025-01-01 2025-03-31 0001889983 kvac:FounderShares1Member us-gaap:IPOMember 2021-09-30 2021-09-30 0001889983 2021-09-30 2021-09-30 0001889983 kvac:FounderShares1Member 2021-09-30 2021-09-30 0001889983 us-gaap:PrivatePlacementMember 2023-07-27 0001889983 kvac:PrivateWarrantsMember 2023-07-27 0001889983 kvac:PrivateWarrantsMember 2023-07-27 2023-07-27 0001889983 us-gaap:PrivatePlacementMember 2023-07-27 2023-07-27 0001889983 us-gaap:IPOMember 2026-03-31 0001889983 kvac:PublicWarrantMember us-gaap:IPOMember 2023-07-27 0001889983 kvac:PublicWarrantMember 2023-07-27 0001889983 kvac:PublicWarrantMember 2023-07-27 2023-07-27 0001889983 kvac:PublicShareMember 2023-07-27 2023-07-27 0001889983 us-gaap:OverAllotmentOptionMember 2023-07-27 0001889983 kvac:PublicWarrantMember us-gaap:IPOMember 2023-07-27 2023-07-27 0001889983 us-gaap:IPOMember 2023-07-27 0001889983 kvac:NonRedeemableOrdinaryShareMember 2024-01-01 2024-12-31 0001889983 kvac:RedeemableOrdinaryShareMember 2024-01-01 2024-12-31 0001889983 kvac:NonRedeemableOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 kvac:RedeemableOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 kvac:PrivateWarrantsMember 2025-12-31 0001889983 kvac:PrivateWarrantsMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 kvac:KVACMSCaymanLimitedMember 2026-01-01 2026-03-31 0001889983 kvac:KVACCaymanLimitedAcquirerMember 2026-01-01 2026-03-31 0001889983 kvac:PublicShareMember 2026-03-31 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-26 0001889983 srt:ScenarioForecastMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-04-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-12-19 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-11-18 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-10-21 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-09-19 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-08-18 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-27 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-06-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-05-20 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-04-25 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-03-24 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-02-24 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-01-22 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-12-23 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-11-20 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-10-28 0001889983 2026-01-22 2026-01-22 0001889983 2026-01-22 0001889983 srt:ScenarioForecastMember 2026-01-27 2026-07-27 0001889983 us-gaap:CommonStockMember 2025-07-22 2025-07-22 0001889983 2025-07-22 0001889983 2025-07-22 2025-07-22 0001889983 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-07-22 0001889983 2025-07-27 0001889983 kvac:TrustAccountMember 2024-10-27 2025-07-27 0001889983 us-gaap:CommonStockMember 2024-10-25 2024-10-25 0001889983 2024-10-25 0001889983 2024-10-25 2024-10-25 0001889983 kvac:SponsorMember 2026-03-31 0001889983 us-gaap:IPOMember 2026-01-01 2026-03-31 0001889983 kvac:PublicShareMember 2026-01-01 2026-03-31 0001889983 2023-07-27 2023-07-27 0001889983 us-gaap:PrivatePlacementMember 2026-03-31 0001889983 us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0001889983 us-gaap:IPOMember 2023-07-27 2023-07-27 0001889983 2025-03-31 0001889983 2024-12-31 0001889983 us-gaap:RetainedEarningsMember 2025-03-31 0001889983 us-gaap:CommonStockMember 2025-03-31 0001889983 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001889983 us-gaap:RetainedEarningsMember 2024-12-31 0001889983 us-gaap:CommonStockMember 2024-12-31 0001889983 us-gaap:RetainedEarningsMember 2026-03-31 0001889983 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001889983 us-gaap:RetainedEarningsMember 2025-12-31 0001889983 kvac:OrdinarySharesNotSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001889983 kvac:OrdinarySharesNotSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0001889983 kvac:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001889983 kvac:OrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0001889983 2026-05-06 0001889983 kvac:WarrantsEachExercisableForOneOrdinaryShareAtAnExercisePriceOf1150Member 2026-01-01 2026-03-31 0001889983 kvac:OrdinaryShares00001ParValueMember 2026-01-01 2026-03-31 0001889983 kvac:UnitsEachConsistingOfOneOrdinaryShareAndOneRedeemableWarrantToAcquireOneOrdinaryShareMember 2026-01-01 2026-03-31 0001889983 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001889983 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001889983 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001889983 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001889983 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 iso4217:USD kvac:Segment pure iso4217:USD shares shares http://fasb.org/srt/2026#ChiefExecutiveOfficerMember P3D 00-0000000 Q1 0001889983 false --12-31 10-Q true 2026-03-31 2026 false 001-41753 KEEN VISION ACQUISITION CORPORATION D8 37 Greenbriar Drive Summit NJ 07901 (203) 609-1394 Units, each consisting of one ordinary share and one redeemable warrant to acquire one ordinary share KVACU NASDAQ Ordinary Shares, $0.0001 par value KVAC NASDAQ Warrants KVACW NASDAQ Yes Yes Non-accelerated Filer true true false true 5506521 9098 11206 95225 25550 104323 36756 13153709 57003115 13258032 57039871 106907 73496 2788022 2668022 1582880 1315880 4477809 4057398 2990000 2990000 7467809 7047398 1090446 1090446 4822346 4822346 13153709 57003115 0.0001 0.0001 500000000 500000000 4416075 4416075 4416075 4416075 442 442 -7363928 -7011084 -7363486 -7010642 13258032 57039871 232844 171333 324931 739504 324931 739504 92087 568171 3163724 3163724 6404652 6404652 0.07 0.07 0.1 0.1 4416075 4416075 4416075 4416075 -0.03 -0.03 -0.02 -0.02 4416075 442 -7011084 -7010642 444931 444931 92087 92087 4416075 442 -7363928 -7363486 4416075 442 -4199554 -4199112 1339504 1339504 568171 568171 4416075 442 -4970887 -4970445 92087 568171 324931 739504 69675 62860 33411 -74013 -269108 -308206 120000 600000 44294337 44174337 -600000 267000 269622 120000 600000 44294337 -43907337 869622 -2108 -38584 11206 54548 9098 15964 444931 1339504 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Keen Vision Acquisition Corporation (the “Company” or “we”, “us” and “our”) is a blank check company incorporated on June 18, 2021, under the laws of the British Virgin Islands for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an early stage company and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage companies and emerging growth companies. The Company has selected December 31 as its fiscal year end.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2026, the Company had not commenced any operations. All activities through March 31, 2026 relate to the Company’s formation, the initial public offering (the “Initial Public Offering” or “IPO”) and activities necessary to identify a potential target and prepare for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income and changes in unrealized appreciation of Trust Account assets from the proceeds derived from the Initial Public Offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Financing</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The registration statement for the Company’s Initial Public Offering was declared effective on July 24, 2023. On July 27, 2023, the Company consummated the Initial Public Offering of 14,950,000 units (the “Public Units”), which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at $10.00 per Public Unit, generating gross proceeds of $149,500,000 to the Company. Each Public Unit consists of one ordinary share (“Public Share”) and one redeemable warrant (“Public Warrant”) to purchase one ordinary share at an exercise price of $11.50 per share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 678,575 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to KVC Sponsor LLC (the “Sponsor”), generating gross proceeds of $6,785,750 to the Company. Each Private Placement Unit consists of one ordinary share (“Private Placement Share”) and one redeemable warrant (“Private Warrant”) to purchase one ordinary share at an exercise price of $11.50 per whole share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Transaction costs amounted to $6,597,980, consisting of $2,990,000 of underwriting commissions, $2,990,000 of deferred underwriting commissions and $617,980 of other offering costs. In addition, at July 27, 2023, cash of $1,593,452 was held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. Cash of $151,368,750 was transferred to the Trust Account on July 27, 2023. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="font-weight: bold;"><i>Trust Account</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <span style="background-color: white">The aggregate amount of $151,368,750 ($10.125 per Public Unit) held in a trust account (“Trust Account”) established for the benefit of the Company’s public shareholders and maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee, will be invested only in U.S. government treasury bills, with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds in the Trust Account will not be released until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period) or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the redemption of all of the Company’s public shares if the Company is unable to complete its initial Business Combination within nine months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination, including Automatic Extension Period), subject to applicable law.</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="font-weight: bold;"><i>Business Combination</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company will provide its shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with an Initial Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company shall not consummate such Business Combination unless (i) the Company has net tangible assets of at least US$5,000,001 after payment of the deferred underwriting commissions, either immediately prior to, or upon such consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such Business Combination; or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from seeking redemption rights with respect to 15% or more of the public shares without the Company’s prior written consent. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially $10.125 per public share, subject to increase of up to an additional $0.10 per public share per each three-month extension in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their public shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company will proceed with a Business Combination if (i) the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination or (ii) otherwise the Company is exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended; and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor and any of the Company’s officers or directors that may hold Founder Shares (as described in Note 5) (as defined the “initial shareholders”) are identical to the Public Shares except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below. The Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial business combination, with respect thereto, a vote to amend the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, or a tender offer by the Company prior to a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 22, 2024, the Company entered into a non-binding letter of intent (the “LOI”) with a business combination target (the “Target”), regarding a potential business combination involving the Target and its subsidiaries (the “Proposed Transaction”). The Target is a clinical stage biopharmaceutical company based in Boston, U.S., focusing on i) the research, development, manufacture and use of self-developed pioneering human stem cell-based bioengineering technology platform for novel drug discovery; and ii) the development of next-generation cell and gene therapies for a range of difficult-to-treat or incurable diseases. With a pipeline of therapeutic candidates, the Target’s several experimental gene therapies have already obtained U.S. Food and Drug Administration (“FDA”) Investigational New Drug (IND) approvals as ongoing clinical trials at multiple premier hospitals in the U.S. with active patient enrolments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The LOI is non-binding and no agreement providing for any Proposed Transaction or any other transaction or the participation by either party therein will be deemed to exist unless and until definitive agreements have been executed. Pursuant to the IPO prospectus dated July 24, 2023, (Registration No. 333-269659) filed by the Company for the initial public offering (the “IPO”), the Company is entitled to an automatic six-month extension to complete a business combination (the “Automatic Extension Period”) after the execution of the LOI and has 15 months from the closing of its IPO, or October 27, 2024, to complete its initial business combination period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2024, the Company has entered into merger agreement (“Merger Agreement”) with Medera Inc. (“Medera”). The Company will incorporate a Cayman Islands exempted company (“Acquirer”) to be a direct wholly-owned subsidiary of the Company for the purpose of the merger of Company with and into the Acquirer (the “Reincorporation Merger”), in which Acquirer will be the surviving entity. Acquirer upon its incorporation will form a Cayman Islands exempted company to be a direct wholly-owned subsidiary of Acquirer (“Merger Sub”) for the purpose of effectuating the Acquisition Merger. Upon the terms and subject to the conditions of the Merger Agreement, (a) The Company will reincorporate by merging with and into the Acquirer, in which the Acquirer will be the surviving company and the Company will cease to exist, and (b) promptly after the Reincorporation Merger, the parties intend to effect a merger of Merger Sub with and into Medera, in which Medera will be the surviving entity (the “Acquisition Merger”, together with the Reincorporation Merger, the “Mergers” and together with the other transactions related thereto, the “Proposed Business Combination”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> At the effective time of the Acquisition Merger, each outstanding Medera Ordinary Share (excluding treasury shares and dissenting shares) will be cancelled and converted into the right to receive a number of Acquirer Ordinary Shares equal to the Exchange Ratio, as outlined in the Merger Agreement. The number of Acquirer Ordinary Shares to be delivered by Acquirer to shareholders of Medera at the Closing is based on a net value of $622,560,000 for 100% of Medera’s issued and outstanding ordinary shares, with each Acquirer Ordinary Share valued at $10.00. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On October 25, 2024, in connection with the stockholders vote at the Annual Meeting, 8,545,348 shares were redeemed by certain shareholders at a price of approximately $10.81 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $92,398,989. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On October 25, 2024, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer &amp; Trust Company (the “Trust Amendment”). Pursuant to the Trust Amendment, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement for a period of nine months from October 27, 2024 to July 27, 2025, by depositing into the Trust Account $200,000 for all remaining public shares (the “Extension Payment”) for each one-month extension. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company will have until July 27, 2025 (unless further extended) to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within nine months (the “Combination Period”), the Company may extend the period of time to consummate a Business Combination up to four times, each by an additional one month each time (for a total of 24 months including Automatic Extension Period) by depositing into the Trust Account $200,000 (approximately $0.10 per share per each month extension) to complete a Business Combination (the “Paid Extension Period”). Any funds which may be provided to extend the time frame will be in the form of a loan to the Company from the Sponsor. The terms of any such loan have not been definitively negotiated, provided, however, any loan will be interest free and will be repayable only if the Company completes a Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On July 22, 2025, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer &amp; Trust Company (the “Trust Amendment II”). Pursuant to the Trust Amendment II, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement II for a period of nine months from July 27, 2025 to January 27, 2026, by depositing into the Trust Account $0.03 for each remaining public shares (the “Extension Payment”) for each one-month extension. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On July 22, 2025, in connection with the stockholders vote at the Annual Meeting, 1,582,306 shares were redeemed by certain shareholders at a price of approximately $11.43 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $18,091,743. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On January 22, 2026, the Company entered into an amendment to the Investment Management Trust Agreement, with Continental Stock Transfer &amp; Trust Company (the “Trust Amendment III”). Pursuant to the Trust Amendment III, the Company has the right to extend the time for KVAC to complete its business combination (the “Business Combination Period”) under the Trust Agreement III for a period of seven months from January 27, 2026 to July, 2026, by depositing into the Trust Account $120,000 for all remaining public shares (the “Extension Payment”) for each three-month extension. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On January 22, 2026, in connection with the stockholders’ vote at the Annual Meeting, 3,781,900 shares were redeemed by certain shareholders at a price of approximately $11.71 per share, including interest generated and extension payments deposited in the Trust Account, in an aggregate amount of $44,294,337. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 26, 2026, the Company entered into a binding letter of intent (“LOI”) with Medera and Novoheart Group Limited, a British Virgin Islands company and wholly owned subsidiary of Medera (“NVH”). The LOI replaces the prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI pursuant to a mutual release agreement entered into by the parties. In connection with the execution of the LOI, the parties also executed a standard termination and mutual release agreement relating to the current Merger Agreement between the Company and Medera.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> As of the date of this report, the Company has extended seventeen times, and so it now has until July 27, 2026 to consummate a business combination. Pursuant to the terms of the current amended and restated memorandum and articles of association and the trust agreement between the Company and Continental Stock Transfer &amp; Trust Company, LLC, in order to extend the time available for the Company to consummate the initial business combination, the Company’s insiders or their affiliates or designees, must deposit into the Trust Account $200,000 on or prior to the date of the applicable deadline. On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, respectively, the Company has deposited in an amount of $200,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, respectively, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="font-weight: bold;"><i>Liquidation</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price of $10.00 per Public Unit. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.125 per share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="font-weight: bold;"><i>Liquidity and going concern</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> As of March 31, 2026, the Company reported a working capital deficit of $4,373,486. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company initially had nine months from the consummation of the Initial Public Offering to consummate the initial Business Combination. If the Company does not complete a Business Combination within nine months from the consummation of the Initial Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Act (As Revised) of the British Virgin Islands. Accordingly, no vote would be required from the shareholders to commence such a voluntary winding up, dissolution and liquidation. However, the Company may extend the period of time to consummate a Business Combination seventeen times (for a total of up to 36 months from the consummation of the Initial Public Offering to complete a Business Combination, including Automatic Extension Period). If the Company is unable to consummate the Company’s Initial Business Combination by July 27, 2026 (unless further extended), the Company will, as promptly as possible but not more than ten business days thereafter, redeem 100% of the Company’s outstanding public shares for a pro rata portion of the funds held in the Trust Account, including a pro rata portion of any interest earned on the funds held in the Trust Account and not necessary to pay taxes, and then seek to liquidate and dissolve. However, the Company may not be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of the Company’s public shareholders. In the event of dissolution and liquidation, the Company’s warrants will expire and will be worthless. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not consummated by July 27, 2026 (unless further extended). These unaudited condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</p> 14950000 1950000 10 149500000 1 11.5 678575 10 6785750 1 11.5 6597980 2990000 2990000 617980 1593452 151368750 151368750 10.125 P185Y 1 0.80 0.50 5000001 0.15 10.125 0.1 5000001 622560000 1 10 8545348 10.81 92398989 200000 200000 0.1 0.03 1582306 11.43 18091743 120000 3781900 11.71 44294337 200000 200000 200000 200000 200000 200000 200000 200000 200000 200000 200000 144670 144670 144670 144670 144670 144670 144670 120000 120000 1 50000 10 10.125 4373486 1 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis of presentation</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">These accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all of the information and notes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2025 included in the Company’s Form 10-K filed with the SEC on March 25, 2026. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principles of consolidation</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited condensed consolidated financial statements include the unaudited condensed financial statements of the Company and its subsidiaries. All significant intercompany transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A subsidiary is the entity in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tbody><tr style="vertical-align: bottom"><td style="width: 32%; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Name</span></span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Background</span></span></td> <td style="width: 2%"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Ownership</span></span></td> </tr><tr style="background-color: rgb(204,238,255)"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC (Cayman) Limited (“Acquirer”)</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on August 28, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Company</span></td> </tr><tr style="background-color: White"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC MS (Cayman) Limited</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on July 10, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Acquirer</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of estimates</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <span style="background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did <span style="-sec-ix-hidden:fc_464230810"><span style="-sec-ix-hidden:fc_1468788771">not</span></span> have any cash equivalents as of March 31, 2026 and December 31, 2025.</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and investment held in Trust Account</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. These securities are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividend income in the accompanying unaudited condensed consolidated statements of income and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant accounting</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares subject to possible redemption</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of the Company’s control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of financial instruments</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820, <i>Fair Value Measurements and Disclosures</i> (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. ASC 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy is categorized into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by the market through correlation or other means.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the unaudited condensed consolidated balance sheets. The fair values of cash and other current assets, accrued expenses, due to a related party are estimated to approximate the carrying values as of March 31, 2026 and December 31, 2025 due to the short maturities of such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">    <span style="-sec-ix-hidden:fc_1457673650">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1791815065">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1919409724">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_2022191326">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited condensed consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the unaudited condensed consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s management determined that the British Virgin Islands and Cayman Islands are the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were <span style="-sec-ix-hidden:fc_1432770074"><span style="-sec-ix-hidden:fc_308775795">no</span></span> unrecognized tax benefits and <span style="-sec-ix-hidden:fc_2073083718"><span style="-sec-ix-hidden:fc_449309593">no</span></span> amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s tax provision was zero for the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the Initial Public Offering, the proceeds held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss) per share</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="white-space: nowrap; text-align: justify"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2026</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2025</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Basic and diluted net income (loss) per share:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; text-align: justify">Numerators:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt">Dividend income earned in investments held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">324,931</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_544241243">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">739,504</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_717716062">-</span></td> <td style="width: 1%; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 1.5pt">Total expenses</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(97,186</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(135,658</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(101,410</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(69,923</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left; padding-bottom: 2.5pt">Total allocation to redeemable and non-redeemable ordinary shares</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">227,745</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(135,658</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">638,094</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(69,923</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="font-weight: bold">Denominators:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-bottom: 2.5pt">Weighted-average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">3,163,724</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">6,404,652</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.07</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.03</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.10</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.02</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related parties</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of credit risk</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent issued accounting standards</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis of presentation</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">These accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all of the information and notes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2025 included in the Company’s Form 10-K filed with the SEC on March 25, 2026. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principles of consolidation</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited condensed consolidated financial statements include the unaudited condensed financial statements of the Company and its subsidiaries. All significant intercompany transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A subsidiary is the entity in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tbody><tr style="vertical-align: bottom"><td style="width: 32%; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Name</span></span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Background</span></span></td> <td style="width: 2%"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Ownership</span></span></td> </tr><tr style="background-color: rgb(204,238,255)"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC (Cayman) Limited (“Acquirer”)</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on August 28, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Company</span></td> </tr><tr style="background-color: White"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC MS (Cayman) Limited</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on July 10, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Acquirer</span></td> </tr></tbody> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company and each of the following entities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tbody><tr style="vertical-align: bottom"><td style="width: 32%; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Name</span></span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Background</span></span></td> <td style="width: 2%"> </td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: bold;">Ownership</span></span></td> </tr><tr style="background-color: rgb(204,238,255)"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC (Cayman) Limited (“Acquirer”)</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on August 28, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Company</span></td> </tr><tr style="background-color: White"><td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KVAC MS (Cayman) Limited</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Cayman Islands company<br/> Incorporated on July 10, 2024</span></td> <td style="vertical-align: bottom; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by the Acquirer</span></td> </tr></tbody> </table> A Cayman Islands company Incorporated on August 28, 2024 1 A Cayman Islands company Incorporated on July 10, 2024 1 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of estimates</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <span style="background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did <span style="-sec-ix-hidden:fc_464230810"><span style="-sec-ix-hidden:fc_1468788771">not</span></span> have any cash equivalents as of March 31, 2026 and December 31, 2025.</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and investment held in Trust Account</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of March 31, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. These securities are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividend income in the accompanying unaudited condensed consolidated statements of income and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets. </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant accounting</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. Warrants that meet the requirement for equity classification are recorded at their fair value at the time of issuance and are not revalued at each reporting date. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the unaudited condensed consolidated statements of income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants are classified as equity.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares subject to possible redemption</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to the occurrence of uncertain future events and considered to be outside of the Company’s control. Accordingly, as of March 31, 2026 and December 31, 2025, 1,090,446 and 4,822,346 ordinary shares subject to possible redemption, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s unaudited condensed consolidated balance sheets, respectively. </p> 1090446 4822346 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of financial instruments</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820, <i>Fair Value Measurements and Disclosures</i> (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. ASC 820 establishes a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy is categorized into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by the market through correlation or other means.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the unaudited condensed consolidated balance sheets. The fair values of cash and other current assets, accrued expenses, due to a related party are estimated to approximate the carrying values as of March 31, 2026 and December 31, 2025 due to the short maturities of such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">    <span style="-sec-ix-hidden:fc_1457673650">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1791815065">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1919409724">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_2022191326">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">13,153,709</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">    <span style="-sec-ix-hidden:fc_1457673650">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1791815065">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted<br/> Prices In<br/> Active<br/> Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td> <td style="font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Assets:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt">U.S. Treasury Securities held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">57,003,115</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_1919409724">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 4pt double; text-align: right">     <span style="-sec-ix-hidden:fc_2022191326">-</span></td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table> 13153709 13153709 57003115 57003115 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited condensed consolidated financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the unaudited condensed consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. The Company’s management determined that the British Virgin Islands and Cayman Islands are the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were <span style="-sec-ix-hidden:fc_1432770074"><span style="-sec-ix-hidden:fc_308775795">no</span></span> unrecognized tax benefits and <span style="-sec-ix-hidden:fc_2073083718"><span style="-sec-ix-hidden:fc_449309593">no</span></span> amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025, respectively. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s tax provision was zero for the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the Initial Public Offering, the proceeds held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss) per share</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company calculates net income (loss) per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of March 31, 2026 and December 31, 2025, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants to purchase an aggregate of 15,628,575 and 15,628,575 shares, respectively, in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, the diluted income (loss) per share is the same as basic income (loss) per share for the periods presented. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="white-space: nowrap; text-align: justify"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2026</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2025</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Basic and diluted net income (loss) per share:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; text-align: justify">Numerators:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt">Dividend income earned in investments held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">324,931</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_544241243">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">739,504</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_717716062">-</span></td> <td style="width: 1%; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 1.5pt">Total expenses</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(97,186</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(135,658</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(101,410</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(69,923</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left; padding-bottom: 2.5pt">Total allocation to redeemable and non-redeemable ordinary shares</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">227,745</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(135,658</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">638,094</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(69,923</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="font-weight: bold">Denominators:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-bottom: 2.5pt">Weighted-average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">3,163,724</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">6,404,652</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.07</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.03</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.10</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.02</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr></tbody></table> 15628575 15628575 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net income (loss) per share presented in the unaudited condensed consolidated statements of income is based on the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="white-space: nowrap; text-align: justify"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2026</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended<br/> March 31, 2025</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-<br/> Redeemable<br/> Ordinary<br/> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td>Basic and diluted net income (loss) per share:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="font-weight: bold; text-align: justify">Numerators:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt">Dividend income earned in investments held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">324,931</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_544241243">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">739,504</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden:fc_717716062">-</span></td> <td style="width: 1%; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 1.5pt">Total expenses</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(97,186</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(135,658</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(101,410</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(69,923</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left; padding-bottom: 2.5pt">Total allocation to redeemable and non-redeemable ordinary shares</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">227,745</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(135,658</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">638,094</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(69,923</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="font-weight: bold">Denominators:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-bottom: 2.5pt">Weighted-average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">3,163,724</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">6,404,652</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td> <td style="border-bottom: Black 4pt double; text-align: right">4,416,075</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.07</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.03</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">0.10</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(0.02</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr></tbody></table> 324931 739504 97186 135658 101410 69923 227745 -135658 638094 -69923 3163724 4416075 6404652 4416075 0.07 0.07 -0.03 -0.03 0.1 0.1 -0.02 -0.02 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related parties</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of credit risk</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent issued accounting standards</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 3 – INITIAL PUBLIC OFFERING</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the Initial Public Offering on July 27, 2023, the Company sold 14,950,000 Public Units, which includes 1,950,000 Public Units upon the full exercise by the underwriter of its over-allotment option, at a purchase price of $10.00 per Public Unit. Each Public Unit consists of one Public Share and one Public Warrant to purchase one ordinary share at an exercise price of $11.50 per share (see Note 6). </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> All of the 14,950,000 public shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</p> 14950000 1950000 10 1 1 1 11.5 14950000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 4 – PRIVATE PLACEMENT</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Simultaneously with the closing of the Initial Public Offering on July 27, 2023, the Company consummated a private placement of 678,575 Private Placement Units, at a price of $10.00 per Private Placement Unit. Each Private Placement Unit consists of one Private Placement share and one Private Warrant to purchase one ordinary share at an exercise price of $11.50 per whole share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Private Placement Units are identical to the Public Units sold in the Initial Public Offering except for certain registration rights and transfer restrictions.</p> 678575 10 1 1 1 11.5 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 5 – RELATED PARTY TRANSACTIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Founder Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <span style="background-color: white">In September 2021, the Company issued an aggregate of 3,737,500 Founder Shares to the initial shareholders, including an aggregate of up to 487,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (see Note 6) for an aggregate purchase price of $25,000. As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (See Note 7).</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Administrative Services Arrangement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> An affiliate of the Sponsor agreed that, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, administrative and support services, as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $10,000 per month for these services commencing on the closing date of the Initial Public Offering for 15 months (or up to 21 months including Automatic Extension Period). As of March 31, 2026 and December 31, 2025, the unpaid services fee was $150,000 and $120,000, respectively, and is presented in amount due to a related party in the accompanying unaudited condensed consolidated balance sheets. For the three months ended March 31, 2026 and 2025, the Company incurred $30,000 and $30,000 in fees for these services, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Related Party Extensions Loan</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company will have to consummate a Business Combination by July 27, 2026. However, if the Company anticipates that it may not be able to consummate a Business Combination within 21 months (including automatic extension period), the Company may extend the period of time to consummate a Business Combination up to four times, four times by an additional one month each time to complete a Business Combination. The Sponsor or its affiliates or designees will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the event that the Company are unable to close a Business Combination unless there are funds available outside the Trust Account to do so. Such notes would either be paid upon consummation of the initial Business Combination or at the lender’s discretion, converted upon consummation of the Business Combination into additional private units at a price of $10.00 per unit. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On each of October 28, 2024, November 20, 2024, December 23, 2024, January 22, 2025, February 24, 2025, March 24, 2025, April 25, 2025, May 20, 2025 and June 23, 2025, the Company issued an unsecured promissory note in an amount of $200,000 to the Sponsor, pursuant to which such amount has been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2025. On each of July 23, 2025, August 18, 2025, September 19, 2025, October 21, 2025, November 18, 2025 and December 19, 2025, the Company has deposited in an amount of $144,670 into the Trust Account in order to extend the amount of available time to complete a business combination until January 27, 2026. On each of January 26, 2026 and April 27, 2026, the Company has deposited in an amount of $120,000 into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. The notes are non-interest bearing and are payable upon the closing of a business combination. In addition, the notes may be converted, at the lender’s discretion, into additional Private Units at a price of $10.00 per unit. As of March 31, 2026 and December 31, 2025, the note payable balance was $2,788,022 and $2,668,022, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Advance from a Related Party</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> As of March 31, 2026 and December 31, 2025, the Company had a temporary advance of $1,582,880 and $1,315,880 from the Sponsor, respectively. The balance is unsecured, interest-free and has no fixed terms of repayment.  </p> 3737500 487500 0.20 25000 10000 150000 120000 30000 30000 10 200000 200000 200000 200000 200000 200000 200000 200000 200000 144670 144670 144670 144670 144670 144670 120000 120000 10 2788022 2668022 1582880 1315880 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 6 – SHAREHOLDERS’ DEFICIT</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Ordinary Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company is authorized to issue 500,000,000 ordinary shares at par $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> As of March 31, 2026 and December 31, 2025, 4,416,075 and 4,416,075 Ordinary Shares were issued and outstanding excluding 1,090,446 and 4,822,346 Ordinary Shares subject to possible redemption, respectively, so that the initial shareholders will own 20% of the issued and outstanding shares after the Initial Public Offering (excluding the sale of the Private Units and assuming the initial shareholders do not purchase any Units in the Initial Public Offering). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no Founder Shares are currently subject to forfeiture (see Note 7). </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Warrants</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Each holder of a warrant shall be entitled to purchase one ordinary share at an exercise price of $11.50. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable after the consummation of a Business Combination. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. The Company has agreed that as soon as practicable after the closing of a Business Combination, the Company will use its best efforts to file, and within 90 days following a Business Combination to have declared effective, a registration statement covering the ordinary shares issuable upon exercise of the warrants. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 90 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant: </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30 days’ prior written notice of redemption to each warrant holder,</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the ordinary share equals or exceeds $16.5 per share, for any 20 trading days within a 30 trading days period ending on the <span style="-sec-ix-hidden:fc_1163283176">third</span> trading day prior to the notice of redemption to Public Warrant holders, and</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tbody><tr style="vertical-align: top"><td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, there is a current registration statement in effect with respect to the issuance of the ordinary share underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.</span></td> </tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In addition, if in connection with a Business Combination, the Company (a) issues additional Ordinary Shares or equity-linked securities at an issue price or effective issue price of less than $9.35 per share (with such issue price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such issuance to the Company’s initial stockholders, or their affiliates, without taking into account any Founders’ Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions), and (c) the Fair Market Value (as defined below) is below $9.35 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (a) the Fair Market Value or (b) the price at which the Company issues the ordinary shares or equity-linked securities, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Fair Market Value and the price at which the Company issues ordinary shares or equity-linked securities. The “Fair Market Value” shall mean the volume weighted average reported trading price of the ordinary shares for the twenty (20) trading days starting on the trading day prior to the date of the consummation of the Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Private Warrants are identical to the Public Warrants underlying the Public Units being sold in the Initial Public Offering except that Private Placement Units will not be transferable, assignable or saleable until 30 days after the completion of the Company’s Business Combination and will be entitled to registration rights. </p> 500000000 0.0001 one 4416075 4416075 4416075 4416075 1090446 4822346 0.20 1 11.5 P90D P90D P5Y 0.01 P30D 16.5 P20D P30D 9.35 0.60 9.35 1.15 16.5 1.65 P20D P30D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 7 – COMMITMENTS AND CONTINGENCIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Risks and Uncertainties</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management continues to evaluate the impact of the Russia-Ukraine war and the conflict in Israel and Palestine on the industry and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Registration Rights</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Pursuant to a registration rights agreement entered into on July 24, 2023, the holders of the Founder Shares, Private Placement Units (including securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital loans or extension loans and are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><i>Underwriter Agreement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The underwriters are entitled to a cash underwriting discount of 2% of the gross proceeds of the Initial Public Offering, or $2,990,000, upon the closing of the Business Combination, which is shown as deferred underwriting expenses on the accompanying unaudited condensed consolidated balance sheets. </p> 0.02 2990000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 8 – SEGMENT INFORMATION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 280, <i>Segment Reporting</i>, establishes standards for companies to report in their unaudited condensed financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Company’s CODM has been identified as the <span style="-sec-ix-hidden:fc_1563613632">Chief Financial Officer</span>, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which includes formation and operating costs and interest and dividend earned on investments held in Trust Account which are included in the accompanying statements of income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The key measures of segment profit or loss reviewed by the CODM are earned on investments held in Trust Account and formation and operating costs. The CODM reviewed earned on investments held in Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.</p> The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. 1 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;">NOTE 9 – SUBSEQUENT EVENTS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"><span style="font-weight: bold;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with ASC Topic 855, <i>Subsequent Events</i>, which establishes general standards of accounting for and disclosure of events that occur after the unaudited condensed consolidated balance sheet date, the Company has evaluated all events or transactions that occurred after the unaudited condensed consolidated balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.1pt; text-align: justify; text-indent: -26.1pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On April 27, 2026 the Company issued an unsecured promissory note in an amount of $120,000 to the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until July 27, 2026. </p> 120000 false false false false